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ABSTRACT 
 
     This dissertation mainly focuses on the investigation of the cellular membrane 
trafficking of mesoporous silica nanoparticles.  We are interested in the study of 
endocytosis and exocytosis behaviors of mesoporous silica nanoparticles with desired 
surface functionality. The relationship between mesoporous silica nanoparticles and 
membrane trafficking of cells, either cancerous cells or normal cells was examined. Since 
mesoporous silica nanoparticles were applied in many drug delivery cases, the 
endocytotic efficiency of mesoporous silica nanoparticles needs to be investigated in 
more details in order to design the cellular drug delivery system in the controlled way.  
     It is well known that cells can engulf some molecules outside of the cells through a 
receptor-ligand associated endocytosis. We are interested to determine if those 
biomolecules binding to cell surface receptors can be utilized on mesoporous silica 
nanoparticle materials to improve the uptake efficiency or govern the mechanism of 
endocytosis of mesoporous silica nanoparticles. Arginine-glycine-aspartate (RGD) is a 
small peptide recognized by cell integrin receptors and it was reported that avidin 
internalization was highly promoted by tumor lectin. Both RGD and avidin were linked 
to the surface of mesoporous silica nanoparticle materials to investigate the effect of 
receptor-associated biomolecule on cellular endocytosis efficiency. The effect of ligand 
types, ligand conformation and ligand density were discussed in Chapter 2 and 3.    
      Furthermore, the exocytosis of mesoporous silica nanoparticles is very attractive for 
biological applications. The cellular protein sequestration study of mesoporous silica 
nanoparticles was examined for further information of the intracellular pathway of 
endocytosed mesoporous silica nanoparticle materials. The surface functionality of 
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mesoporous silica nanoparticle materials demonstrated selectivity among the materials 
and cancer and normal cell lines.  We aimed to determine the specific organelle that 
mesoporous silica nanoparticles could approach via the identification of harvested 
proteins from exocytosis process. 
      Based on the study of endo- and exocytosis behavior of mesoporous silica 
nanoparticle materials, we can design smarter drug delivery vehicles for cancer therapy 
that can be effectively controlled. The destination, uptake efficiency and the cellular 
distribution of mesoporous silica nanoparticle materials can be programmable. As a result, 
release mechanism and release rate of drug delivery systems can be a well-controlled 
process. The deep investigation of an endo- and exocytosis study of mesoporous silica 
nanoparticle materials promotes the development of drug delivery applications. 
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DISSERTATION ORGANIZATION 
 
     This dissertation is composed of five chapters. Chapter 1 is a review focusing on the 
application of mesoporous silica nanoparticle materials in intracellular drug delivery of 
molecules and proteins. Topics are related to the cellular delivery of molecules or 
proteins into animal or plant cells. The drugs, dyes, cell membrane impermeable 
macromolecules (proteins or DNA) can be delivered by utilizing mesoporous silica 
nanoparticles as transportation vehicles. Chapter 2 is a journal article accepted by 
Chemistry - A European Journal. The importance of ligand conformation and density of a 
small peptide RGD on the association of cell surface receptor integrin was highlighted. 
Chapter 3 and 4 are ready for submission. Chapter 3 is a study of selective intracellular 
protein sequestration and removal from cells utilizing differently surface functionalized 
magnetic mesoporous silica nanoparticle materials. Chapter 4 is a study investigating to 
linkage of biomolecules onto mesoporous silica nanoparticles surface via biotin-avidin 
interaction. The biotin moiety on mesoporous silica nanoparticles is the ligand for avidin. 
With noncovalent immobilization of avidin, the endocytosis behavior of mesoporous 
silica nanoparticles are manipulated by immobilized protein types, protease, and thiol 
reducing reagent. Chapter 5 is a general conclusion summarizing the importance of this 
research done in this dissertation. 
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CHAPTER 1. GENERAL INTRODUCTION  
 
APPLICATION OF MESOPOROUS SILICA NANOPARTICLES IN 
INTRACELLULAR DRUG DELIVERY  
 
Modified from a chapter published in Methods in Enzymology 2012, vol 508, 41-59 
I-Ju Fang and Brian G. Trewyn 
 
Abstract 
Delivery of drugs and molecules to eukaryote animal and plant cells can be enhanced 
when mediated by mesoporous silica nanoparticle (MSN) materials. We describe, in 
detail, the synthesis of several different MSN materials used for the transport of drug 
molecules, neurotransmitters, macromolecules, etc. across the cell membrane, and in 
some cases, plant cell walls. We also summarized several considerations that need to be 
addressed when utilizing MSN materials with biological systems to avoid complicating 
experiments. 
 
Introduction 
Transporting drugs and molecules through cell membranes has recently been the topic 
of a significant amount of research in the area of drug delivery and controlled release. 1-4 
Several different types of drug carriers or “vehicles” have been developed for this task 
including polymers, liposomes, dendimers, and inorganic nanoparticles.5-9 Utilizing these 
vehicles has several advantages over conventional dosage methods including decreased 
drug inactivation, increased efficacy, and reduced non-specific interactions to name just a 
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few. One type of inorganic nanoparticle that has been successfully applied as a 
controlled-release drug delivery system is mesoporous silica nanoparticle (MSN) 
materials.10-15 In the early 1990s mesoporous silica materials were discovered 
independently by researchers at the Mobil Oil Corporation in the US and by researchers 
at Waseda University in Japan.16-18 The unique characteristics of MSN material make it 
ideal for applications in catalysis, separations, sensors, and drug delivery.19-21  
The delivery of small molecules (neurotransmitters and anticancer drugs) and large 
biomolecules (proteins and DNA) into animal and plant cells has been demonstrated by 
utilizing MSN material as the transport vehicle and by taking advantage of the endocytic 
character of MSN materials. Due to the 
unique system of parallel, individual 
pores, the MSN nanocarrier system has 
demonstrated “zero release” of drugs 
prior to the MSN carriers reaching the 
targeted cells (Figure 1).22 In certain 
instances, MSN based drug delivery 
systems are triggered by external stimuli 
and release their cargo at the desired 
destination. Because of the nature of the 
cargo, the interior and exterior surface of 
the MSN needs to be specifically functionalized for the purpose of drug delivery. The key 
points and related syntheses are discussed in detail below. 
 
Figure 1. Transmission electron 
micrograph of a mesporous silica 
nanoparticle. 
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Intracellular delivery into animal cells utilizing MSN 
Several reports have demonstrated the uptake of MSN material by eukaryote cells 
through endocytosis processes. The process of MSN internalization makes it possible to 
utilize this unique delivery vehicle to deliver many different types of molecules 
efficiently. One particular area of interest is in the uptake of cell membrane impermeable 
molecules that cannot be internalized by cells directly through standard dosage means. 
With the help of MSN materials, procedures have been developed to increase the 
efficiency of animal and plant cell uptake of various molecules.  
 
Delivery of drugs 
Regular pore MCM-41-type MSN material has several characteristics as drug and 
molecule delivery and controlled release devices that distinguish it from other systems, 
including a high surface area (>800 m2 g-1), an easily tunable pore size (2-10 nm), and 
unique functional surface chemistry.16 These MSN structural properties make it a 
desirable material for loading, delivering, and releasing drugs in controlled manners. The 
drugs that are loaded and released are unique and require specific MSN properties. One 
such example of molecular properties that need to be addressed with utilizing MSN 
materials for drug delivery is the hydrophilic or hydrophobic nature of the drug/molecule. 
Different strategies for the synthesis of MSNs, the drug loading, and the drug release are 
adapted to optimize the utility of MSN.  
For hydrophilic drugs, the delivery of a neurotransmitter (ATP) and an antibiotic 
(vancomycin) to astrocyte cells by pore-capped MSN materials has been demonstrated.23 
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The procedures for the synthesis of drug loaded, cadmium sulfide nanoparticle (CdS) 
capped MSN were completed as follows: 2-(propyldisulfanyl) ethylamine functionalized 
mesoporous silica nanosphere (linker-MSN) were synthesized as the core MSN support 
with a disulfide reducible ligand. The CdS nanoparticles were ligated with 
mercaptoacetic acid to produce acid-CdS nanoparticles, whose monodispersed size is 
compatible with the regular pore size of MSNs through an amidation reaction (Figure 2). 
The most important aspect of this type of nanoparticle based controlled release system 
was the cleavable disulfide bond triggered by dithiothreitol (DTT) and mercaptoethanol 
(ME). As a result of this complete capping, no drug leakage occurred until the MSN 
material was exposed to a disulfide reducing agent. The linker-MSN (100 mg) was 
dispersed in a PBS solution (pH 7.4) of ATP or vancomycin at a concentration of 5 mM 
for 24 h. The mercaptoacetic acid-functionalized CdS nanoparticles (0.15 mmol) were 
dissolved in 2 mL of PBS with a constant concentration of vancomycin or ATP to 
prevent drug diffusion from MSN pores. The amide linking agent, 1-[3-
(dimethylamino)propyl]-3-ethylcarbodiimide hydrochloride (EDC) (57.5 mg), was 
Figure 2. Schematic representation of the designed stimuli-responsive drug loading, 
capping, and release system mediated by mesoporous silica nanoparticle materials. 
Examples of inorganic nanoparticles that have been successfully employed as pore caps 
include cadmium sulfide, iron oxide, and gold. 
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introduced to the CdS/drug mixture solution. The reaction mixture was stirred for 24 h, 
followed by centrifuging for 3 min. The resulting products obtained were ATP- or 
vancomycin-loaded, CdS-capped MSN with loading densities of 83.9 and 30.3 mol % for 
vancomycin and ATP, respectively. This system successfully released neurotransmitters 
triggered by perfusion of mercaptoethanol in the presence of astrocytes that caused an 
increase in the concentration of intracellular Ca2+ ion. In addition to the CdS nanoparticle 
caps, we developed iron oxide nanoparticle capped MSN (magnet-MSN) as nanocarriers, 
that made the entire system magnetic and, after cellular internalization, cells can be 
moved under the control of a magnetic field.24  
In another system, the MSN mediated intracellular delivery of cysteine (Cys) was 
demonstrated 25. Cysteine is toxic and not stable in the extracellular matrix so the cargo, 
Cys, was covalently bound to the interior of thiol functionalized MSN through a disulfide 
bond bridge (Cys-MSN). This disulfide bond between Cys and MSN material was 
reduced by the intracellular antioxidants, including nicotinamide adenine dinucleotide 
hydride (NADH), dihydrolipoic acid (DHLA), and glutathione. Cys molecules were 
released from MSN material into the cytoplasm. Potentially, Cys-MSN can be applied to 
several chronic inflammation disorders caused by low intracellular concentrations of 
glutathione.  
Because the silanol-based surface of MSN material is very hydrophilic, there is low 
affinity for the adsorption of hydrophobic drugs that are only slightly water-soluble. This 
hydrophobic characteristic is common among most anticancer drugs and adds 
complications to their use. Anionic surfactant templated MSNs were designed for the 
delivery of some of these hydrophobic drugs.26 The anticancer drug resveratrol was used 
6	  	  
as the guest molecule to demonstrate the potential delivery system. The anionic surfactant 
was used as a template to form the pore framework in order to create a hydrophobic 
environment inside the MSN pores with high affinity of resveratrol. The release of 
resveratrol was surfactant-assisted, the surfactant template diffused from the pores with 
the resveratrol cargo when MSN material was dispersed in dilute PBS solution (Figure 3). 
For the synthesis of the anionic surfactant templated MSN material, the structure 
directing agent, undec-1-en-11-yltetra(ethylene glycol) phosphate mono-ester surfactant 
(PMES, 0.5 mmol) was dissolved in 100 mL of nanopure water and stirred vigorously at 
80 °C for 1h. Then, aminopropyltrimethoxysilane (APTMS) was injected dropwise into 
the solution, followed by the addition of tetraethylorthosilicate (TEOS, 4.5 mmol) at the 
rate of 20 mL per hour. The reaction solution was stirred vigorously at 80 °C for 10 min 
and then aged at 80 °C for 24 h. The as-made product, PMES-MSN, was isolated by 
filtration, washed with nanopure water and methanol, and dried under vacuum at room 
temperature overnight. Loading resveratrol followed the synthesis and characterization of 
PMES-MSN by dissolving 0.05 mmol resveratrol in 100 mL of 10 % ethanol in water.  
PMES-MSN (300 mg) were added to 30 mL of this solution and stirred for 24 h at room 
Figure 3. Schematic representing the process of loading resveratrol in to PMES-MSN 
and the release of the drug along with PMES surfactant. 
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temperature. To avoid the photo-isomerization of resveratrol under UV light the material 
was protected from light. Resveratrol was released from the pores of PMES-MSN when 
dispersed in dilute PBS and stirred at room temperature.  
Double delivery of drugs 
One unique advantage of MSN material is the intrinsic nanoparticle morphology of 
two independent surfaces. MSN materials have an interior pore surface and an exterior 
surface that can be selectively and independently functionalized. Thus, MSN material can 
co-deliver chemical, protein and genomic material, utilizing these surfaces of the MSN. 
For example, the pores of MSN were loaded with cyclic adenosine monophosphate 
(cAMP) and capped with a sugar derivative of insulin protein (Figure 4a).27 The unique 
mechanism that we designed for this co-delivery system allowed for both the insulin and 
cAMP to be released dependent upon the concentration of extracellular glucose. Using 
Figure 4. Schematic representation of the [glucose] dependent extracellular release 
of G-Ins and the intracellular release of cAMP (a) and a quantitative display of the 
[glucose] dependant release of cAMP (b). 
a)	  
b)	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this insulin bonding scheme, the concentration of glucose manipulated the kinetics of 
release of insulin and cyclic AMP. The insulin was covalently bound to the MSN surface 
by the binding between the phenylboronic acid of MSN exterior and the vicinal diols of 
insulin. This type of binding is reversible in high concentrations of glucose. The insulin 
capped cAMP loaded MSNs were an efficient self-regulated device for the concentration 
of glucose. 
To synthesize the phenylboronic acid functionlized MSNs (BA-MSNs), aminopropyl 
functionalized MSN (AP-MSN) was used as the precursor for the further derivativization 
of the boric acid group on MSN surface. The AP-MSN (400 mg) was dispersed in 20 mL 
DMSO and 0.9 mmol 4-carboxyphenylboronic acid (CBA) was activated with 0.9 mmol 
N-hydroxysuccinimide (NHS) and 1 mmol 1-ethyl-3-(3-dimethylaminopropyl) 
carbodiimide hydrochloride (EDC) in 5 mL DMSO, stirring at room temperature for at 
least 15 min before adding it to the AP-MSN suspension. The mixture was stirred at room 
temperature overnight, followed by filtration and washing with DMSO, water and 
methanol to remove excess CBA. 
Insulin was gluconic acid functionalized according to the literature (G-Ins), and was 
further labeled with fluorescein dye (FITC) for in vitro controlled release studies. 28 G-Ins 
(200 mg) was dissolved in 50 mL sodium carbonate buffer (0.1 M, pH 9) and then 
reacted with 2.5 mL FITC in DMSO at 1 mg mL-1 was added while the G-ins solution 
was stirred in dark to avoid fluorescence quenching. The reaction was stirred for another 
2 h at room temperature until 1 M NH4Cl was added to quench excess FITC. After 
stirring for 1 h, the solution was dialyzed in phosphate-buffered saline and freeze-dried to 
obtain FITC labeled G-Ins (FITC-G-Ins). The ratio of FITC to G-ins was estimated by 
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measuring the absorbance ratio between 495 nm and 280 nm corresponding to the 
absorption band for fluorescein and G-Ins, respectively. 
To load cAMP into the mesopores and cap with G-Ins, the BA-MSN (100 mg) was 
stirred in 1 mM cAMP solution (10 mL PBS, 154 mM, pH 7.4) for 24 h in the dark. Then, 
FITC-G-Ins (200 mg) was added to the suspension and the mixture was stirred in dark 
overnight, followed by filtration and extensive washing with PBS to remove physically 
adsorbed cAMP and non-associated FITC-G-Ins from the exterior surface of the MSN 
material. The resulting precipitate was isolated and dried under high vacuum. The loading 
of cAMP and FITC-G-Ins was calculated by subtracting the amount of cAMP/FITC-G-
insulin remaining in the supernatant from the amount of cAMP/FITC-G-insulin originally 
in the reaction mixture. 
Cyclic AMP loaded FITC-G-Ins-MSN (6 mg) was dispersed in 3 mL of PBS with the 
introduction of different concentrations of glucose triggers. Aliquots (1.5 mL) were 
removed after stirring for two days in the dark at room temperature, followed by 
separation by centrifugation. To measure the kinetics of release, cAMP loaded FITC-G-
Ins-MSN (30 mg) was dispersed in 15 mL of PBS with 50 mM glucose (Figure 4b). 
Aliquots (1.2 mL) were removed at the specific time intervals from the suspension, 
followed by centrifugation. The release kinetics of FITC-G-Ins and cAMP were 
monitored by fluorescence emission spectroscopy and HPLC, respectively. 
Delivery of cell membrane impermeable macromolecules 
Most macromolecules cannot penetrate cell membranes through an endocytic 
pathway because of their size and/or charge. However, MSN materials can be used as 
carriers to promote the cellular internalization of macromolecules. Cell membrane 
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impermeable proteins and polysaccharides were delivered into cells by the aid of MSN 
materials utilizing recently developed large pore MSN synthesis techniques that contain 
these macromolecules in the mesopore framework. There are two types of large pore 
MSN materials: one is MCM-41 type and the other is SBA-15 type. 16,29 
MCM-41-type MSN with large pore diameter (5.4 nm) is synthesized for the 
intracellular delivery of cell membrane impermeable protein cytochrome c by employing 
mesitylene, a pore-expanding agent, used in conjunction with the traditional MCM-41 
surfactant template.30 The activity of released cytochrome c remained after loading and 
releasing from the pores of the MSN. 
 To synthesize MCM-41-type large pore MSN, cetyltrimethylammonium bromide 
(CTAB, 2.7 mmol) was dissolved in a solution of 480 mL water and 3.5 mL of 2M 
NaOH, followed by addition of mesitylene (48.8 mmol) to the solution. The mixture was 
stirred vigorously until the solution was stable at 80 °C. Tetraethyl orthosilicate (21.9 
mmol) was then introduced to the solution dropwise at a rate of 1 mL min-1. The reaction 
mixture was stirred at 80 °C for 2 h. The resulting white precipitate (as-made MSN) was 
isolated by filtration, washed with methanol, and dried under vacuum at high temperature 
(100 °C) for 12 h. The structure-template surfactant, CTAB, and mesitylene were 
removed from the pores of the as-made MSN by acid extraction. A suspension of 1.0 g of 
the as-made MSN material was stirred for 6 h at 50 °C in a 100 mL methanol with 0.75 
mL concentrated hydrochloric acid. The template-free solid product was then isolated via 
filtration and dried under vacuum at room temperature for 12 h. For loading of FITC-
labeled cytochrome c into the pores of the MSN, 5 mL of the protein solution ranging 
from 0.4 to 8 mg mL-1 in PBS were stirred for 6 h at room temperature with 20 mg of 
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MSN. The suspensions were centrifuged and the loading was determined by measuring 
the difference in absorption of the Soret band of cytochrome c at 410 nm in the 
supernatant before and after loading. The isolated protein-MSN composites were dried 
under vacuum in the dark at room temperature to avoid fluorescence quenching for 12 h. 
Suspensions of the FITC-cytochrome c-loaded MSN in PBS were prepared at the 
concentration of 100 µg mL-1. The release of FITC-cytochrome c from MSN materials 
was monitored by UV-Vis. 
Large pore MSN can accommodate the loading of several large macromolecules that 
are too large for standard MCM-41 type MSN. Dextran is a polysaccharide complex that 
has a dynamic diameter of approximately 8 nm. Mesoporous polymer-silica hybrid 
nanoparticles were synthesized for the delivery of macromolecules, like dextran, into 
cells 31. A uniform, thin polymer layer was formed on the MSN surface upon the addition 
and heat treatment of the polymer monomer (methacrylic acid (MAA)). When dextran 
was loaded into polymethacrylic acid-coated MSN (PMAA-MSN) at low pH (lower than 
5), a stable complex between PMAA-MSN and dextran was formed because of the 
hydrogen bonding interactions occurring between carboxylic acid groups on the PMAA 
and the hydroxyl group of dextran. However, the hydrogen bond would be diminished 
when the MAA becomes deprotonated at pH levels greater than the pKa of 
polymethacrylic acid (pKa = 4.85). Polymer-silica nanoparticles are biocompatible and 
have demonstrated to be efficiently engulfed by cells. As a result the PMAA layer on 
MSN played an important role in controlling the loading and release of dextran. At low 
pH, dextran was loaded into PMAA-MSNs and then released in higher pH, such as 
intracellular pH.  
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For the synthesis details, the large pore SBA-15 type MSN materials were 
synthesized as follows. First, a triblock copolymer Pluronic P104 (EO27PO61EO27; 7 g) 
was dissolved in a 1.6 M HCl aqueous solution (270 g), the temperature was stabilized at 
56 °C and tetramethyl orthosilicate (10.6 g) was quickly added into the solution. 
Uniquely to this MSN material, temperature is an important parameter in controlling the 
particle and pore morphology. After stirring for 24 h, the reaction solution was 
transferred to a Teflon-lined high-pressure autoclave for hydrothermal treatment at 
150 °C for 24 h. The resulting large pore MSN product was isolated by filtration, washed 
with water and methanol, and dried under high temperature. The template removal of 
MSN was conducted through a high-temperature calcination process at 550 °C. To form a 
uniform polymer layer on the interior surface of MSN material, the methacrylic acid 
monomer (MAA; 0.190 g), ethylene dimethacrylate cross-linker (EDMA; 0.11 g), and 
radical initiator α,α’-azoisobutyronitrile (AIBN; 16 mg) were dissolved in 1.25 mL of 
dichloromethane. The monomer diffused into the mesopores of the large pore MSN (1 g) 
via a wet impregnation method. After 2 h of drying at 40 °C in order to remove the 
dichloromethane, the mixture was transferred into a Schlenk reactor and subjected to 
freeze-vacuum-thaw cycles three times with liquid nitrogen. The mixture was kept at 
35 °C for 6 h under vacuum, and the polymerization of MAA was performed at 60 °C for 
6 h, 100 °C for 1 h, and 120 °C for 1 h. The product, PMAA-MSN, was washed with 
chloroform and ethanol several times and dried at 80 °C under vacuum. The PMAA-
MSN hybrid materials were directly loaded with FITC-Dextran (40 kDa) prepared in pH 
3 buffer by mixing PMAA-MSN (3.2 mg) with 5 mL of the FITC-Dextran solution. After 
the suspension was stirred for 24 h, the final product was centrifuged and washed with a 
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buffer solution three times. The amount of FITC-Dextran loaded on the PMAA-MSN 
was determined by UV-Vis spectroscopy. The supernatant solution was analyzed at 451 
nm. The sample was dried under vacuum at room temperature. 
The release profile of 40 kDa FITC-Dextran from the PMAA-MSNs in a pH 7 
solution was measured at room temperature using the FITC-Dextran-loaded PMAA-MSN 
at pH 3. PMAA-MSN successfully delivered the dextran cargo into eukaryote cells. 
MSN Mediated Delivery of DNA 
Polyamidoamine (PAMAM) dendrimer has proven to be an efficient gene 
transfection reagent. Second generation PAMAM (G2-PAMAM) was used to complex 
DNA onto the exterior surface of MSN material.32 In detail, G2-PAMAM (0.11 mmol) in 
ethanol was added to an isocyanatopropyl-functionalized MSN (ICP-MSN) suspension 
and stirred for 20 h to form covalent urea bonds between the primary amines of the 
PAMAM and the ICP groups of the MSN.  
The results demonstrated that the G2-PAMAM-MSN could form a complex with 
plasmid DNA at weight ratios larger than 1:5. Also, the G2-PAMAM-MSN-DNA 
complex protects DNA from digestion by nuclease enzymes because of the shielding of 
PAMAM-MSN complex. Significant GFP expression was observed in the cytoplasm 
after G2-PAMAM-MSN-DNA complexes were internalized by cells. Once the 
complexes were internalized, the DNA was released from the surface of the PAMAM-
MSN and diffused into the cell cytoplasm. 
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Delivery into plant cells utilizing MSN 
As previously mentioned, surface functionalized MSN is often used as vehicles to 
transport guest molecules into animal cells, however utilizing MSN to carry guest 
molecules into plant cells is a much more challenging task. Compared to animal cells, the 
internalization of MSN into plant cells is limited because plant cells have a thick 
cellulose cell wall to give structure support and protection from environmental stress. To 
further investigate the endocytosis of MSN materials by plant cells, Lin, Wang, and 
coworkers developed a MSN technology to study the endocytosis of MSN and delivery 
of chemicals and genomic material into plant cells and plant protoplasts (cells with the 
cell wall enzymatically removed).33 For plant cells without cell walls, MSN could be 
directly internalized into the cytoplasm and deliver and release DNA, which was 
subsequently expressed. For plant cells containing cell walls, a gene gun bombardment 
technique is necessary to get the MSN through the cell wall and into plant cells (Figure 
5a). We will introduce some basic ideas for development MSN delivery systems for plant 
cells, how to apply MSN to plant science, and how to successfully deliver small drug 
molecules to plant cells in a controlled fashion. 
The study of endocytosis of MSN by plant protoplasts. 
Surface functionality of MSN material plays an instrumental role in the endocytosis 
of MSN by protoplast cells. Tagging the MSN material with FITC dye in a manner 
similar to that stated above allowed for observation of the dynamic distribution of MSN 
materials in plant cells. Protoplasts failed to internalize MSN materials that were not 
surface functionalized. However, a triethylene glycol (TEG) functional group covalently 
attached to the MSN surface made it possible for protoplasts to uptake MSN.  
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The MSN material (200 nm in diameter) was covalently doped with fluorescein as 
described above to visualize the internalization of MSN by plant cells and protoplasts. To 
limit the diffusion of the TEG ligand into the pores, the exterior surface of the MSN was 
covalently coated with TEG by a post synthesis grafting method prior to acid extraction 
of the surfactant template. The synthesis of the TEG ligand was achieved by reacting the 
TEG precursor 1-[2-(2-bromo-ethoxy)-ethoxy]-2-methoxy-ethane with 3-
aminopropyltrimethoxysilane overnight in refluxing ethanol. The surfactant template was 
removed by acid extraction following successful attachment of the TEG ligand. The 
product of this reaction was directly available for endocytosis experiments.  
Endocytosis experiments: 
Protoplasts (106 cells mL-1) were incubated with 10 µg TEG coated FITC labeled 
MSN (TEG-FITC-MSN) in media overnight. To remove physically adsorbed TEG-FITC-
MSN that had not been internalized by the protoplasts, the mixtures were incubated with 
K4 medium and centrifuged for 10 min at 100g at room temperature. Only protoplasts at 
the interphase were collected for analysis.  
Although protoplasts could directly internalize TEG-FITC-MSN, the delivery of 
MSN materials to intact plant cells is more attractive and practical for plant research. For 
this reason, the synthesis and functionalization of MSN was modified to codeliver 
Figure 5. Illustration of the disulfide reducer controlled uncapping of MSN pores and 
the subsequent release of β-oestradiol (a) and the fluorescent foci per transgenic 
cotyledon grown in the presence (gray bars) and absence (black bars) of DTT (b). 
a)	   b)	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bioactive agents through the common gene gun bombardment method often used in the 
field.  
Gene gun bombardment  
Gene gun bombardment is a method for the physical introduction of DNA into plant 
cells containing cell walls. The gene gun is utilized to bombard the plant cell wall with 
many DNA coated metal particles by using compressed helium as the propellant. The 
metal particles commonly used for gene gun bombardment include gold, tungsten, 
palladium, rhodium, platinum and iridium. They are coated with DNA, accelerated by 
helium gas, and bombard the plant cells. The metal particles (0.45 to 1.5 µm in diameter) 
punch holes in and pass through the cell wall and enter the plant cells, leaving the DNA 
cargo inside the cells. The DNA coated metal particles randomly bombard the cells, no 
targeting is currently possible with this method. For example, the metal particles are 
localized everywhere in the cell including the nucleus and cytoplasm. Once the DNA 
cargo diffuses from the surface of the metal carrier, it has the opportunity to influence the 
intracellular genetic process.  
Density is an important property of the metals used for this process, pure silica 
particles cannot gain enough momentum with helium propellant to break through the cell 
wall. To combine the advantageous properties of gold particles (density, biocompatibility, 
and DNA affinity) with the highly porous framework of MSN, a new gold nanoparticle 
capped MSN system was designed and synthesized. To synthesize acid functional gold 
nanoparticles, hydrogen tetrachloroaurate (III) hydrate (7.63 x 10-4 mol) was dissolved in 
15 mL methanol, followed by the quick introduction of 1.8 x 10-3 mol 11-
mercaptoundecanoic acid and 3 mL acetic acid. Under vigorous stirring, 0.4 M sodium 
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borohydride in 30 ml water was added dropwise. The desired 10-15 nm acid 
functionalized-gold nanoparticles were washed with methanol, ethyl ether, and water and 
dried under vacuum. These acidic gold nanoparticles were coupled to amino groups on 
the MSN surface by standard amidation linker chemistry. To coat the gene gun 
microcarrier with DNA, gold capped-MSN material was dispersed in ethanol with the 
DNA of interest, and the tube was vortexed. Once the gene gun microcarrier was loaded 
with DNA, it was immersed into liquid nitrogen immediately to avoid agglomeration of 
DNA-bound MSN material and freeze dry the sample before bombarding into the plant 
cells.  
The unique porous structure of MSN makes it possible for the dual delivery of 
bioactive agents: chemicals and proteins in the porous framework and genomic material 
adsorbed to the gold nanoparticle-coated exterior. For example, the interior of the MSN 
can be loaded with a chemical promoter to increase the efficiency of gene expression and 
the exterior surface of MSN can be coated with plasmid DNA for the desired gene 
expression. In the past, only nucleic acids could be carried by the nonporous gold 
particles. The development of mesoporous silica nanoparticles technology in plant cells 
opened the door for co-delivery of DNA and its corresponding inducer. Furthermore 
MSN material was capped with gold nanoparticles by the cleavable disulfide bond linked 
amide bond. The intracellular delivery could be precisely controlled by the addition of 
DTT. 
 Co-delivery of genetic material and its activator into plant cell 
Codelivery of chemicals and DNA was great step forward in the area of plant science 
genomic research. It opened the door for scientists to look into methods for control in 
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plant gene transfection. We used the transformation process to deliver genetic 
components into plant cells by using DNA-bound gold nanoparticle-capped drug-loaded 
MSN.  
The design of DNA delivery system: 
MSN material was used as a vehicle to carry GFP plasmid DNA and its inducer β-
oestradiol into plant cells. To retain the β-oestradiol in the pores, the MSN material was 
capped with gold nanoparticles, the synthesis of which is outlined above. To dictate the 
release of the β-oestradiol the gold nanoparticles were covalently linked to the MSN 
material by disulfide linkers that were reduced in the presence of disulfide reducing 
agents. Only DNA bound gold nanoparticles capped β-oestradiol loaded MSNs treated 
with DTT showed the GFP expression in the cytoplasm. Prior to DTT treatment, loaded 
drugs (gene inducer) are trapped inside the pores, and did not influence gene expression.  
The MSN material with primary amine linkers containing a cleavable disulfide bond 
(linker-MSN) was synthesized as the MSN precursor for plant cell delivery. To load the 
pores with the plasmid activator, linker-MSN (100 mg) was mixed with 5.0 x 10-2 M β-
oestradiol at room temperature for 24 h. To covalently cap the linker-MSN, the gold 
nanoparticles were functionalized with 11-mercaptoundecanoic acid. These gold 
nanoparticles were introduced into the MSN material suspension with the same 
concentration of the cargo molecules with the amide coupling reagent (80 mg) for 
another 24 h. Gold capped β-oestradiol loaded MSN material was isolated by washing 
and centrifuging prior to DNA coating. 
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DNA/MSN coating: 
To adsorb plasmid DNA to the surface of gold (Au) capped β-oestradiol loaded MSN 
material, plasmid DNA (1 µg) was mixed with 10 ug the MSN complex in 50 µl water 
for 2 h at 23 °C. The optimal ratio of DNA to MSN material was 1:10. 
In summary, the codelivery of gene and its inducerr was achieved successfully by 
combining MSN technology with gene gun bombardment. The drug release was precisely 
controlled with DTT treatment. The GFP plasmid DNA was highly expressed in the plant 
cells (Figure 5b). This demonstrated a successful application of MSN based delivery 
systems to genetic engineering research in plant science. 
Testing biological interactions of MSN on animal cells 
To investigate biological interactions of MSN material on cells, some factors need to 
be taken in consideration. Some of these important issues are discussed below. 
Issues with serum and serum-free media on the uptake and cell interaction with MSNs 
Cells usually are cultured in media containing either horse or fetal bovine serum for 
proliferation. Cells take up essential nutrients from media including serum proteins. 
When cells were treated with MSN material, serum in the media caused an effect on the 
cellular behavior. Recently, serum-free media has been utilized during experiments with 
cells and MSN material to avoid this effect that occurs when serum is present. It is not 
entirely clear what causes this effect in the presence of serum but one hypothesis is that 
serum adsorbs to the surface of the MSN material, and interferes with the MSN/cell 
interaction or causes the MSN material to aggregate. What we know for certain is that, 
serum in the media decreased the uptake efficiency of MSN by all cell lines tested. The 
degree of nanoparticle aggregation in serum containing media influenced both the 
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endocytosis efficiency and kinetics. In summary, MSN material was engulfed by cells 
more efficiently and at a faster rate in serum-free media than in the standard 10 percent 
serum media. 
The difference between proliferation and viability 
Cell proliferation and viability are important parameters for the biological study of 
MSN material. Cell proliferation is defined as the cellular growth rate or is a quantified 
value for the daughter cell population.34 Cell viability is a quantification of the number of 
live cells and is usually expressed as a percentage of the control.35,36 Viability assays are 
important when initially seeding the cells onto a plate and to estimate the cytotoxicity of 
nanoparticles. For example, by measuring the viability, we can determine the cell density 
needed to be seeded in the plate to form a monolayer for further experiments at a desired 
time. We can gain information on the cytotoxicity of nanoparticles or the release 
efficiency of MSN based-anticancer drug delivery systems. Many reagents are used to 
monitor or estimate the viability and proliferation of cells. For proliferation assays, 
changes in nucleic acid content are most commonly measured; but for viability assays, 
dye reagents are employed that can distinguish the cells from non-cell species and cell 
membrane integrity. For example, the Guava ViaCount assay employees two dyes to 
determine cell status. The first dye enters all cells (live and dead) and bind to intracellular 
DNA. The second dye enters only dead cells, live cells exclude this dye because of the 
presence of an intact cell membrane. As a result, dead cells, viable cells, and non-cell 
species are distinguished by this fluorescent dye system. 
Cell viability with MSN treatments is also an interesting property to investigate. Cell 
viability tests are run to understand the conditions and limits that are associated with 
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MSN biocompatibility. Many controls are needed to evaluate the cytotoxicity of 
nanoparticles vs the cytotoxicity of molecules that are carried by the nanoparticles.  
The purpose of the trypan blue 
Trypan blue is a stain used to quantify live cells by labeling dead cells exclusively. 
Because live cells have an intact cell membrane, trypan blue cannot penetrate the cell 
membrane of live cells and enter the cytoplasm. In a dead cell, trypan blue passes through 
the porous cell membrane and enters the cytoplasm. Under light microscopy analysis, 
only dead cells have a blue color. Trypan blue is also used to eliminate false positives 
from occurring during cell counting by flow cytometry.32,37,38 Fluorescein labeled MSN 
can be either internalized by cells or they can physically adsorb to the exterior of the cell 
membrane. When these two events occur, it is often difficult to distinguish between them 
by flow cytometry. By adding trypan blue to the solution, the extracellular FITC-MSN 
material is quenched, excluding them from the quantification. Only live cells that have 
internalized the FITC-MSN report a positive result. Trypan blue cannot penetrate the 
membrane of live cells, it will quench all the fluorescence from the physically adsorbed 
MSNs on cell membrane. Thus, we can assure the fluorescence detected by flow 
cytometry is from the cells with internalized fluorescent MSN or cell auto fluorescence. 
Trypan blue solution used is 0.4% (w/w).  
Fluorescently labeling MSN (covalently) for endocytosis experiments 
The endocytic behavior of MSN material has drawn a considerable amount of 
attention in recent years. The endocytosis efficiency is commonly determined by 
measuring the percentage of cells displaying fluorescence above the intensity of cell 
autofluorescence. Generally, MSN materials are covalently labeled with a fluorescent dye, 
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fluorescein isothiocyanate (FITC) is the amine reactive derivative of fluorescein 
commonly the fluorophore employed. For the synthesis of FITC labeled MSNs, FITC is 
reacted with a primary amino group derivatized silane coupling reagent (for example: 
aminopropyl trialkoxysilane coupling reagent).  
For a standard synthesis, 10 mg of aminopropyl trimethoxysilane (APTMS) reagent is 
mixed with FITC for 2 h in anhydrous DMSO or DMF followed by a grafting step with 
pristine MSN material. The FITC forms a covalent bond with the amino group of 
APTMS. As a result, FITC will be well distributed on silica framework. Once FITC 
labeled MSNs are internalized by cells they display a green fluorescence stronger than 
cell autofluorescence. We can determine the endocytic efficiency of MSNs by cells and 
monitor the cellular dynamic distribution of FITC doped MSN by measure the percent of 
fluorescent cells.     
The use of confocal fluorescence microscopy or traditional fluorescence microscopy 
Fluorescence is an important contrasting method in microscopy. Nanoparticles can be 
visualized when labeled with a fluorophore. Both the confocal fluorescence microscopy 
and the traditional fluorescence microscopy can be used to study the cell interaction with 
fluorescent MSN. They use fluorescence to generate the image for the cells with 
endocytosed fluorescent MSN. Although traditional fluorescence microscopy can identify 
if the cells are associated with fluorescent MSN, we cannot distinguish the physically 
adsorbed MSN from the internalized MSN for cells. Confocal microscopy can restrict the 
depth of field. Confocal microscopy eliminates most out of focus light to increase the 
contrast and resolution for images. Only the fluorescence very close to the focal plane is 
detected. Furthermore, confocal microscopy can do z-axis scanning to obtain multi-
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scanning image for one cell at different depths. The purpose to do z-axis scanning is to 
determine if MSN materials are truly associated with cells. By comparing the image 
obtained from the different cell depths, we can conclude the location of MSN materials, 
either just physically adsorbed on cell membrane or endocytosed into the cytoplasm. The 
cells are seeded in prewashed cover slips (22 mm2) and placed in the wells of 6-well 
plates at a concentration of 105 cells mL−1 for 30 h. After 30 h incubation, the cell media 
was replaced with MSN suspension and incubated for an additional 12 h. After the 
removal of the MSN suspension, the cells are washed with PBS buffer three times and 
stained with 57.0 mM nucleus dye for 30 min. These coverslips were removed from 
plates and fixed to glass slides with liquid adhesive. 
To clarify the interaction between cells and MSN, the issues discussed above are 
essential for the study of cellular behavior of MSN need to be well controlled. 
Conclusions 
The detailed methods and studies described in this chapter outline procedures for the 
synthesis of mesoporous silica nanoparticle (MSN) materials, loading the pores and 
external surface with various drug molecules, neurotransmitters, macromolecules and 
genomic material. We also outlined procedures to utilize these delivery devices to 
eukaryote and plant cells. Finally, several factors are identified and reported that  
scientists need to be aware of when researching MSN-based delivery devices. Identifying 
new strategies for releasing substances from the pores and surface of MSN materials will 
dictate the continued success of MSN based delivery systems. In addition, new functional 
groups such as magnetic nanoparticles and surface bound polymers may lead to the new 
development of novel MSN-based delivery devices. 
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Abstract:  
     Recent breakthrough research on mesoporous silica nanoparticle (MSN) materials 
have illustrated their significant potential in biological applications due to their excellent 
drug delivery and endocytotic behavior. We set out to determine if MSN, covalently 
functionalized with conformation specific bioactive molecules (either linear or cyclic 
RGD ligands), behave towards mammalian cells in a similar manner as the free ligands. 
We discovered that RGD immobilized on the MSN surface did not influence the integrity 
of the porous matrix and improved the endocytosis efficiency of the MSN materials. 
Through competition experiments with free RGD ligands, we also discovered a 
conformation specific ligand:integrin association. The interaction between RGD 
immobilized on the MSN surface and integrins plays an important role in endosome 
trafficking, specifically dictating the kinetics of endosomal escape. Thus, covalent 
functionalization of biomolecules on MSN assists in the design of a system for 
controlling the interface with cancer cells. 
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Introduction 
     The unique pore matrix structure and surface chemistry of mesoporous silica 
nanoparticle (MSN) materials have given rise to a number of controlled release systems 
for various drug molecules.[1] An important aspect for the successful administration of 
these MSN-based delivery systems is an understanding of the cellular internalization and 
membrane trafficking processes. Only after understanding these processes will it be 
possible to control them. Along this direction, both the surface chemistry and 
morphology of the MSN have received a significant amount of interest, especially with 
regards to the kinetics and efficiency of cellular internalization.[2]  
     An advantage of MSN materials that has been exploited recently is the surface can be 
functionalized through relatively straightforward chemistry to attach various molecules 
that uniquely effect internalization.[2a,3] However, for MSN-based drug delivery 
investigations it is very important to understand the intracellular trafficking activities. 
The membrane trafficking and endosomal escape of arginine-glycine-aspartate-
functionalized mesoporous silica nanoparticles (RGD-MSN) with different RGD ligand 
conformations is investigated in this study. We, and others, have utilized the large surface 
area, multifunctionality, and low cytotoxicity of MSN as advanced tools in biomedical 
research and have demonstrated their potential in intracellular drug/gene delivery, bio-
imaging, and photodynamic therapy.[4] In order to enhance the efficiency of the MSN in 
these biomedical applications, the mechanism of endocytosis needs to be examined. We 
have previously reported that the endocytosis of MSN by mammalian cells could be 
mediated by different functionalities on the external surface of the MSN and the targeting 
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of specific cell surface receptors has had some recent accomplishments with ligated 
antibodies, polymers and peptides on the surface of MSN.[2a, 3b, 5] 
     We set out to determine if MSN, covalently functionalized with conformation specific 
bioactive molecules, behave toward mammalian cells in a similar manner as the free 
moiety. Integrins, heterodimeric transmembrane proteins, are cell surface receptors that 
mediate attachment of different biomolecules from the extracellular matrix (ECM) or 
other cells to the intracellular cytoskeleton. Many extracellular matrix proteins have a 
common short amino acid sequence that is recognized by the integrin for binding. One 
common tripeptide sequence, arginine-glycine-aspartate (RGD), has an affinity in the µM 
range for some integrins.[6] Researchers are interested in exploiting the interaction 
between the ECM and integrins because of the crucial role it has in cancer metastasis and 
tumor invasion.[7] Herein, we functionalized the external surface of MSN with short RGD 
peptide sequences in an effort to investigate if RGD-MSN is endocytosed through an 
integrin associated pathway, and if the uptake efficiency of RGD-MSN is RGD ligand 
conformation dependant. The uptake efficiency and the endocytic pathway of RGD-
conjugated MSN are also studied and reported. 
Experimental Section 
     Fluorescein isothiocyanate isomer I, methyl β-cyclodextrin, sucrose, N-
hydroxysuccinimide (NHS) and N-cetyltrimethylammonium bromide were purchased 
from Sigma-Aldrich. Tetraethyl orthosilicate, 3-aminopropyltrimethoxysilane, 3-
isocyanate propyltrimethoxysilane were purchased from Gelest. Cyclo-RGDFK was 
purchased from Peptides International. K7RGD was purchased from EZBiolab. 1-ethyl-3-
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(3-dimethyl aminopropyl) carbodiimide (EDC) was purchased from Fluka. All chemicals 
were used as received.  
Preparation of RGD-MSN: 
1a. Synthesis of FITC-MSN:  
     The FITC labeled MSN materials were synthesized by co-condensation method. First, 
fluorescein isothiocyanate (FITC, 12 mg) was stirred with 3-
aminopropyltrimethoxysilane (APTMS, 0.2 mL) in 1.0 mL methanol for 2h at room 
temperature. N-Cetyltrimethylammonium bromide (CTAB, 1.00 g, 2.74 mmol) was 
dissolved in 480 mL of nanopure water. Sodium hydroxide solution (2.00 M, 3.50 mL) 
was introduced to the CTAB solution and the temperature of the mixture was set to 353 K. 
Tetraethoxysilane (TEOS, 5.00 mL, 22.4 mmol) was added dropwise by syringe pump to 
the surfactant solution at a rate 30 ml h-1 under vigorous stirring. And then FITC-
APTMS/methanol solution was introduced quickly to the MSN solution under stirring. 
The mixture was allowed to react for 2 h to give rise to a yellow precipitate. The solid 
materials were dried under high vacuum to yield the FITC-MSN. 
1b. Synthesis of CA-MSN:    
  The FITC-MSN is further functionalized with 3-isocyanate propyltrimethoxysilane 
through the grafting method in order to create the carbamic acid functional group on the 
external surface of MSN. FITC-MSN (1 g) was refluxed in the 80 ml of anhydrous 
toluene with 3-isocyanate-propyltrimethoxysilane (0.25 mL) at 110 °C, followed by 
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washing with deionized water and methanol and dried under high vacuum to yield the as-
synthesized carbamic acid functionalized MSN (CA-MSN). To remove the surfactant 
template (CTAB), 1.0 g of the CA-MSN was refluxed for 6 h in a solution of 1.00 mL of  
HCl (37.4%) in 100 mL methanol at 333 K. The resulting material was filtered, 
extensively washed with deionized water and methanol and dried under high vacuum. 
1c. Synthesis of RGD-MSN with 0.24 mmol g-1 loading (with linear or cyclic 
conformation):     CA-MSN has free carbamic acid residue for the peptide coupling of 
RGD ligand. (either cRGDFK or K7RGD, see Figure 1.) 50 mg CA-MSN was activated 
by EDC/NHS chemistry in 10 mM PBS buffer (10 ml, pH 7.4) for 2 hours, and then 
filtrated and washed with water in order to remove all unreacted EDC and NHS. After the 
unreacted EDC/NHS was removed, MSN was redispersed in 10 mM PBS buffer (10 ml, 
pH 7.4) with the introduction of peptide (40 mg K7RGD or 13 mg cRGDFK). The MSN 
suspension was stirred overnight, followed by wash with water and methanol, and dried 
under vacuum. MSN with the immobilization of K7RGD is called linear RGD-MSN, and 
MSN with the immobilization of cRGDFK is called cyclic RGD-MSN. ( The pKa values 
of amino acid of peptides are summarized in table 1.) 
 
Figure 1. The structure of cRGDFK (a) and K7RGD (b) 
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Table 1.  The pKa value of amino acid 
 
 
 
 
 
 
Biological Experiment 
 
Reagents and materials  
HeLa and MCF-7 cell lines were obtained from American Tissue Culture Collection 
(ATCC). Trypan blue solution (0.4%, w/w) were purchased from Sigma–Aldrich. 
Trypsin (1×, 0.25%) in 0.1% EDTA without calcium and magnesium was purchased 
from Fisher Scientific. SYTO®RNASelect™ endosome marker was purchased from 
Invitrogen. 
 
 
 K R G D F 
pKa1(COOH) 2.18 2.17 2.34 1.88 1.83 
pKa2(NH3+) 8.95 9.04 9.6 9.6 9.13 
pKa of side 
chain) 
10.53 12.48  3.65  
Side chain 
group 
(CH2)4NH2 (CH2)3NHCH(=NH)NH2 H CH2COOH (C6H5)CH2 
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Cell line maintenance 
HeLa cells were maintained in D-10 media in T75 flasks using DMEM (Dulbucco’s 
modified Eagle’s medium) supplemented with 10% equine serum, l-glutamine, penicillin, 
streptomycin, and gentamicin. HeLa cells were split every 2–3 days. 
MCF-7 cells were maintained in D-10 media in T75 flasks using DMEM (Dulbucco’s 
modified Eagle’s medium) supplemented with 10% bovine serum, l-glutamine, penicillin, 
streptomycin, gentamicin, and bovine insulin. MCF-7 cells were split every 5-6 days. 
 
Viability test 
     Cell viability tests of the HeLa cells and MCF-7 cells with and without MSN were 
studied by Guava ViaCount assay (Guava Technologies, Inc.; Hayward, CA). Cells were 
seeded in six well plates with a density of 1 × 105 cells mL-1 in 3 mL of D-10 medium for 
30 h. After 30 h incubation with D-10 medium, cells were treated with the MSN 
suspension. Experiments were designed for all MSN materials at concentrations of 0, 1, 
10, 25, 50, and 100 µg mL−1 in serum-free medium. After 12 hour incubation of MSN 
suspension in serum-free media at 37℃ and 5% CO2, the cells were trypsinized, 
centrifuged and resuspended in 1 ml D-10 medium. The cells in media were then counted. 
The cell viability was determined by the Guava ViaCount cytometry assay.  
Measuring the uptake efficiency of MSNs by cancer cells:  
     The cells were cultured in 6-well plates for 30 h. The cells were then treated with 
MSN suspension at different concentrations. Experiments were designed for all MSN 
with concentrations of 0, 1, 5, 10, 25, 50, and 100 µg mL−1 in serum-free medium for 
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endocytosis.  The cells were incubated with the different concentrations of MSN for 12 h 
at 37 °C in 5% CO2. After 12 h, the cells were washed once with PBS (phosphate-
buffered saline) and trypsinized. After centrifuge, the cells were redispersed in 0.4 % 
trypan blue for 10 min to quench the fluorescence of any MSN physically adhered to the 
exterior surface of the cells. The MSN uptake by cancer cells was measured by flow 
cytometry. The cell without any MSN was set as a control to measure the cell 
autofluorescence. The number of cells with internalized MSN was determined by 
counting the cells showing fluorescence intensity higher than the cell autofluorescence. 
Inhibition and competition assays:  
     HeLa cells or MCF-7 cells were cultured at the density of 1 × 105 cells mL-1 in 6 well 
plates for 30 h in 3 mL of D-10 medium. The D-10 medium was then replaced by 3 mL 
of: (a) DMEM medium for the wells used as control, (b) 450 mM sucrose in DMEM 
medium for the wells used in the clathrin inhibition assay (c). 6.67 mM methyl ß-
cyclodextrin in DMEM medium for the wells used in the cavoloae inhibition assay (d) 
500 µM K7RGD or 250 µM cRGDFK in the integrin competition assay.  
     The cells were incubated with the inhibitors for 30 min. The media were then replaced 
with 3 mL of MSN (40 µg mL-1) in (a) DMEM medium for the wells used as control, (b) 
450 mM sucrose in DMEM medium for the wells used in the clathrin inhibition assay (c). 
6.67 mM methyl ß-cyclodextrin in DMEM medium for the wells used in the caveoloae 
inhibition assay (d) 500 µM K7RGD or 250 µM cRGDFK in the integrin competition 
assay. After 1 h, the cells were washed with DMEM medium and trypsinized. After 
centrifugation, the cells were resuspended in 0.4% trypan blue PBS solution. The 
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influence of the inhibitors on the efficiency of uptake by cancer cells was measured by 
flow cytometry. 
 
Fluorescence confocal microscopy measurements 
     To study the endocytosis of MSN materials, fluorescence confocal microscopy was 
employed. Coverslips (22 mm2) were cleaned with surfactant Contrad 70, nanopure water 
(3×), and 100% methanol, and dried overnight and followed by polylysine coating. The 
polylysine coated coverslips were placed on the bottom of the wells of 6-well plates and 
incubated with 3.0 mL of standard D-10 growth media. Two samples were prepared for 
the confocal microscopy study. First, HeLa or MCF-7 (1.0×105 cells mL−1) were grown 
for 30 h on the coverslips. After 30 h cell growth, the cells were incubated with 10 µg 
mL−1 MSN materials with endosome marker FM 4-64, and grown for an additional 37 h. 
Second, after 50 h of cell growth, the cells were incubated with 10 µg mL−1 MSNs with 
endosome marker FM 4-64, and grown for an additional 17 h. Afterwards, the growth 
media was removed, the cells were washed with PBS (2×), and the cells were then 
reincubated with Hoechst 33258 for 15 min to stain the cell nucleus. These coverslips 
were removed and fixed to glass slides with adhesive. Blue nuclei stain was observed by 
exciting the cells with a UV laser at 340 nm. The green fluorescent from MSN (FITC 
prelabeled) particles internalized by the HeLa cells was visualized by excitation at 488 
nm with an argon laser. The red fluorescent endosome marker was excited at 515 nm. 
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Characterization 
     X-ray diffraction patterns of the MSN materials were obtained in a Scintag XDS-2000 
powder diffractometer using Cu Kα irradiation. Surface analysis of the MSN materials 
was performed by nitrogen sorption isotherms in a Micromeritics Tristar 3000 
sorptometer at 77 K. The surface areas were calculated by the Brunauer–Emmett–Teller 
(BET). The pore size distributions were determined by the Barrett-Joyner-Halenda (BJH) 
method. Particle morphology was observed with a JEOL 840A scanning electron 
microscope with a 10 kV acceleration voltage. The TEM study was completed on a 
Tecnai G2 F20 electron microscope operated at 200 kV. The ζ -potential of the MSN 
materials was measured in a Malvern Nano HT Zetasizer in triplicate. Suspensions (100 
µg mL-1) of each of the materials in phosphate buffer (10 mM, pH 7.4) were prepared.  
 
RGD content determination 
     Peptide K7RGD and cyclo-RGDFK have the maxima absorption at 220 nm. The 
concentrations of peptide in the suspension before and after coupling with CA-MSN after 
centrifuge are determined by UV measurement at 220 nm. The density of peptide bound 
on CA-MSN is equal to the difference of peptide concentration in the suspension between 
before and after peptide coupling with CA-MSN. 
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Results and Discussion 
     MCM-41 type mesoporous silica nanoparticle materials labeled with fluorescein 
isothiocyanate (FITC-MSN) were synthesized by the co-condensation method.[2a] The 
FITC-MSN materials were further functionalized with 3-
isocyanatopropyltrimethoxysilane through a post-synthetic grafting method in order to 
create the carbamic acid functional groups on the external surface of MSN (CA-MSN). 
After grafting the carbamic acid groups, acid extraction was utilized to remove the 
surfactant template. The RGD ligands (cRGDFK or K7RGD) were covalently coupled to 
CA-MSN through the free carbamic acid residues on the external surface of the MSN and 
primary amines on the peptides. The carboxylic acid groups of CA-MSN were activated 
by EDC/NHS chemistry and followed by the introduction of RGD ligands: K7RGD 
immobilized on the surface to give linear RGD-MSN, and cRGDFK to give cyclic RGD-
linear	  RGD-­‐MSN	  cyclic	  RGD-­‐MSN	  
CA-­‐MSN	  
Intensi
ty	  (a.u.
)	  
2	  θ	  degree	  
Figure 2. Low angle X-ray diffraction spectra of CA-MSN, linear RGD-MSN, and 
cyclic RGD-MSN. All MSNs show the typical diffraction patterns of MCM-41 
type with hexagonal symmetry. 	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MSN. The different conformations of RGD ligands were chosen so we could examine the 
effect the 3D structure of the ligand on the surface of MSN has on the recognition of the 
integrin receptors on the cell surface. 
 
 
Figure 3. (a) BET nitrogen adsorption/desorption isotherms of CA-MSN (dark blue), 
linear RGD-MSN (red), and cyclic RGD-MSN (light blue). (b) BJH pore size 
distributions of CA-MSN (dark blue), linear RGD-MSN (red), and cyclic RGD-MSN 
(light blue). All MSNs exhibit the large surface area and the narrow pore size distribution. 
 
 
 
                                          Table 2. BET and BJH parameters 
Sample Surface Area (m2 g-1) Pore Diameter (nm) 
CA-MSN 796 2.4 
linear RGD-MSN 785 2.4 
cyclic-RGD-MSN 737 2.3 
 
 
 
(a)	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  (b)	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  Powder	   X-­‐ray	   diffraction	   (XRD),	   nitrogen	   sorption	   isotherm	   analysis,	   and	  scanning	  and	  transmission	  electron	  microscopy	  (SEM	  and	  TEM,	  respectively)	  were	  employed	   to	   characterize	   all	   MSN	   materials.	   A	   series	   of	   five	   functionalized	   MSN	  materials	  were	  synthesized	  and	  characterized:	  CA-­‐MSN,	  2-­‐linear	  RGD-­‐MSN,	  one	  with	  
3’	   2’	   1’	  
MeOH 
cRGDFK 
amide 
carbons 	   Phenyl group of F 
(b) cyclic RGD-MSN 
3’	   2’	  1’	  
MeOH 
K7RGD 
amide 
carbons 	  
(a) linear RGD-MSN 
Figure 4. 13C solid state CP-MAS NMR spectra of the 
linear RGD-MSN (a) and cyclic RGD-MSN (b). The 
characteristic peaks referring to peptides are shown 
above. 
4’	  
4’	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  0.11	  mmol	   g-­‐1	   and	   one	  with	   0.26	  mmol	   g-­‐1	   ligand	   loading	   (l-­‐RGD-­‐MSN-­‐0.11	   and	   l-­‐RGD-­‐MSN-­‐0.26,	  respectively);	  and	  2-­‐cyclic	  RGD-­‐MSN,	  one	  with	  0.9	  mmol	  g-­‐1	  and	  one	  with	   0.24	   mmol	   g-­‐1	   ligand	   loading	   (c-­‐RGD-­‐MSN-­‐0.09	   and	   c-­‐RGD-­‐MSN-­‐0.24,	  respectively);	   showed	   similarly	   ordered	   hexagonal	   arrangements	   of	   mesopore	  structure	   in	   the	   powder	   XRD	   spectra,	   proving	   that	   the	   post-­‐synthetic	  functionalization	  of	  the	  MSN	  does	  not	  adversely	  affect	  the	  pore	  structure	  (see	  Figure	  2	  and	  Figure	  3).	  All	  linear	  RGD-­‐MSN	  and	  cyclic	  RGD-­‐MSN	  materials	  have	  a	  spherical	  shape,	   a	   particle	  diameter	   ranging	   from	  100	  nm	   to	  200	  nm,	   a	  2.3-­‐2.4	  nm	  average	  pore	   diameter	   and	   a	   surface	   area	   of	   737-­‐785	  m2	   g-­‐1	   (	   Table	   2)	   as	   determined	   by	  electron	  microscopy	   and	   nitrogen	   sorption	   analyses.	   	   The	   RGD	   functionality	   does	  not	  influence	  the	  physical	  nature	  of	  CA-­‐MSN	  such	  as	  the	  structure	  of	  the	  mesopores	  and	  nanoparticle	  morphology.	  The	  amount	  of	  carbamic	  acid	  on	  the	  MSN	  surface	  was	  determined	   by	   solid-­‐state	   direct	   polarization	   29Si	   NMR	   measurements.	   The	   total	  loading	  of	  carbamic	  acid	  on	   the	  MSN	  surface	  was	  determined	  to	  be	  approximately	  
Table 3. Zeta potential and EC50 (µg mL-1) values of the endocytosed 
MSN 
Material 
ζ-
potential 
(mV) 
EC50 
(HeLa) 
EC50 
(MCF-7) 
Ligand loading 
(mmol g-1) 
CA-MSN -17.76 4.0 13.0 0 
linear 
RGD-MSN -9.26 2.1 11.9 0.11 
linear 
RGD-MSN -7.50 1.4 11.1 0.26 
cyclic 
RGD-MSN -10.30 1.8 9.7 0.09 
cyclic 
RGD-MSN -8.94 1.1 7.1 0.24 	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  2.0	  mmol	  g-­‐1.	  The	  successful	  immobilization	  of	  RGD	  ligands	  on	  CA-­‐MSN	  surface	  was	  confirmed	   by	   solid-­‐state	   cross	   polarization	   13C	   NMR	   analysis	   (Fig.	   4).	   The	  characteristic	  peaks	  of	  amide	  carbons	  of	  both	  K7RGD	  and	  cRGDFK	  are	  around	  172	  ppm.	  The	   shift	   in	   the	  phenyl	   group	  of	  phenylalanine	   (F)	   in	   the	  cRGDFK	  peptide	   is	  located	  in	  the	  range	  of	  126	  to	  136	  ppm.	  The	  peaks	  of	  the	  backbone	  carbons	  of	  the	  peptide	   overlap	   with	   the	   peaks	   attributed	   to	   the	   propyl	   groups	   of	   the	  propylcarbamic	  acid	  spacer.	  	  
The amount of RGD on the MSN surface was quantified by UV measurements, the 
density of RGD ligands on both linear RGD-MSN and both cyclic RGD-MSN materials 
are shown in Table 3.  
The zeta potential values for CA-MSN, both linear RGD-MSN, and both cyclic RGD-
MSN materials in 10 mM PBS buffer (pH 7.4) are also shown in Table 3. The CA-MSN 
had the most negative surface charge, while the cyclic and linear RGD-MSN materials 
were less negative by greater than 7.5 mV. This is consistent with the prediction that the 
coupling of cRGDFK and K7RGD with CA-MSN will result in a more positive surface 
because both peptides have a basic pI value (see Table 1). 
In order to investigate the cell targeting characteristics of RGD-MSN, two cell lines 
with different types of RGD dependant integrins on the cell surface were studied (see 
Table 4), HeLa cells (human cervical cancer) and MCF-7 cells (human breast cancer).[8] 
First, the biocompatibility of all types of MSN materials was examined by comparing 
cell viability with and without MSN. Cells were seeded in six well plates with a density 
of 1 × 105 cells mL-1. After 30 h incubation, cells were treated with MSN suspensions at 
the concentrations of 0, 1, 10, 25, 50, and 100 µg mL−1. After 12 h incubation with MSN, 
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the viable cells were quantified. From the viability test results shown on Figure 5, all 
MSN materials tested correspond to good biocompatibility (LC50 greater than 100 µgmL-
1).[9]  
(a) HeLa 
 
(b) MCF-7 
 
 
Figure 5. Cell viability data of MSN materials for Hela (a) and MCF-7 (b).  	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To examine the uptake efficiency of the MSN by cancer cells, they were incubated with 
MSN at different concentrations for 12 h at 37 °C. The HeLa and MCF-7 cells that 
internalized MSN were quantified by flow cytometry. The cells that were not incubated 
with MSN materials were used as a control to measure the cell autofluorescence. The 
number of cells with internalized MSN was determined by counting the cells showing 
fluorescence intensity higher than the cell autofluorescence. Trypan Blue was added to 
quench the fluorescence from extracellular MSN materials that were adsorbed on the cell 
surface.  	  	  	  	  The	  data	  on	  the	  uptake	  efficiency	  of	  MSN	  by	  the	  cells	  are	  shown	  on	  Figure	  6	  and	  the	  EC50	  values	  of	  both	  cell	  lines	  are	  summarized	  in	  Table	  3.	  The	  uptake	  efficiency	  of	  MSN	  by	  the	  cells	  is	  a	  function	  of	  the	  concentration	  of	  MSN	  and	  the	  EC50	  is	  defined	  as	  the	   effective	   concentration	   of	   MSN	   with	   50%	   cellular	   uptake	   and	   is	   determined	  directly	   from	   the	   curve	   in	   Figure	  6.	  A	   series	   of	  RGD-­‐MSN	  materials	  with	  different	  loading	   ligand	   densities	  were	   synthesized	   to	   investigate	   the	   relationship	   between	  endocytosis	   and	   ligand	   density.	   The	   uptake	   efficiency	   for	   l-­‐RGD-­‐MSN-­‐0.26	   is	   2.8	  
Table	  4.	  The	  integrin	  types	  of	  HeLa	  and	  MCF-­‐7	  cell	  lines.	  (RGD	  dependent	  integrin	  is	  in	  red.)	  Cell	  Type	   Integrin	  Type	  HeLa	  	  Human	  cervical	  cancer	  cell	   α1β1,	  α2β1,	  α3β1,	  	  and	  α6β1,	  MCF-­‐7	  Human	  breast	  cancer	  cell	   α2β1,	  αVβ5,	  and	  αVβ3	  Ref:	  Borrirukwanit,	  K.	  Matrix	  Biology	  26	  (2007)	  291–305	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times	   that	  of	  CA-­‐MSN	   in	  HeLa	  and	  about	  1.1	   times	   that	  of	  CA-­‐MSN	   in	  MCF-­‐7.	  This	  demonstrates	   a	   clear	   role	   in	   the	   participation	   of	   the	   receptors	   in	   internalization.	  	  The	  c-­‐RGD-­‐MSN-­‐0.24	  has	  even	  greater	  uptake	  efficiency	  (3.6	  times	  in	  HeLa	  and	  1.8	  times	   in	  MCF-­‐7	  over	  CA-­‐MSN).	   In	  addition,	   the	  c-­‐RGD-­‐MSN-­‐0.24	  mmol	   is	  about	  1.3	  times	  greater	  than	  l-­‐RGD-­‐MSN-­‐0.26	  mmol	  for	  HeLa	  and	  1.5	  times	  greater	  than	  MCF-­‐7,	  see	  Table	  3	  for	  absolute	  values.	  When	  the	  surface	  ligand	  density	  was	  decreased	  by	  
Figure 6. Uptake of the functionalized MSN by HeLa (a) and 
MCF-7 cells (b) (CA-MSN-dark blue, linear RGD-MSN-0.11 
mmol-red, linear RGD-MSN-0.26 mmol-green, cyclic RGD-
MSN—0.09 mmol-light blue, and cyclic RGD-MSN—0.24 mmol-
purple). The number refers to the ligand loading density. 
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  half,	   both	   RGD-­‐MSN	   materials	   demonstrated	   lower	   endocytosis	   efficiency.	  Interestingly,	   l-­‐RGD-­‐MSN-­‐0.26	   mmol	   is	   about	   1.3	   times	   greater	   than	   c-­‐RGD-­‐MSN-­‐0.09	   mmol	   in	   HeLa	   but	   1.1	   times	   less	   in	   MCF-­‐7.	   	   The	   conformation	   and	   surface	  density	   of	   RGD	   ligand	   plays	   an	   important	   role	   on	   the	   control	   of	   cellular	   uptake	  efficiency.	  Thus,	  RGD-­‐MSN	  demonstrated	  selectivity	  between	  two	  cancer	  cell	  lines.	  	  
To determine if the lysine linker contributes to the improved endocytosis efficency of 
linear RGD-MSN, we employed previously demonstrated procedure where trypsin 
cleaved lysine-containing peptides on the surface of MSN.[10] By treating linear RGD-
MSN with trypsin, we determined that the lysine linker, does in fact, contribute to the 
enhanced endocytosis efficiency. When the linear RGD-MSN was treated with trypsin, 
the endocytosis efficiency increased to a higher value (2.8 µg mL-1). These results 
indicate that both the positive lysine residues and RGD ligands contribute to the 
promotion of endocytosis efficiency. Trypsin lyses the lysine space linker on MSN 
surface resulting in the loss of the RGD moiety. Trypsinized RGD-MSN showed a 
decrease in endocytosis efficiency but still greater than CA-MSN (about 1.2 times 
greater).  
The entire series of RGD-MSN materials are internalized more effectively than the 
control CA-MSN by both cancer cell lines tested. The RGD ligand functionality 
improves the accumulation of nanoparticles inside the cells. Cyclic RGD-MSN 
demonstrated lower EC50 values for both cell lines, indicating that the conformation of 
the RGD ligand on the MSN surface influenced the endocytosis efficiency. This is 
consistent with the previous report that the cyclic RGD has a much higher affinity for 
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integrins than linear RGD.[11] The conformation of RGD ligand on the MSN surface plays 
an important role in the specific recognition of receptors on cell surface. 
 
Figure 7. Relative uptake of the MSN by HeLa cells in absence and presence of a series 
of inhibitors: (from left to right) MSN without any inhibitor, MSN with inhibitors 
including 450 mM sucrose, 6.67 mM methyl-β-cyclodextrin, the integrin blocking 
reagent 500 µM K7RGD, and 250 µM cRGDFK. L-RGD-MSN is linear RGD-MSN, and 
C-RGD-MSN is cyclic RGD-MSN.  
 
It was reported that the internalization of MSN by HeLa cells is through an endocytic 
process.[2a] It is well-known that clathrin and caveolin are intracellular proteins that 
regulate cellular trafficking of cargo by endocytosis. Furthermore, the integrins are 
internalized by cells actively undergoing endocytosis by the aid of clathrin or caveolin 
proteins. Thus, we investigated which endocytic pathway mediates the fate of RGD-MSN 
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and how they are related to the integrins. For the inhibition assay, the clathrin inhibitor, 
sucrose, and caveolin inhibitor, methyl-β-cyclodextrin, were utilized.[12] These molecules  
Figure 8. Uptake of the MSN materials by MCF-7 cells in absence and presence of a 
series of inhibitors: MSN without any inhibitor (black), MSN with inhibitors including 
450 mM sucrose (red), 6.67 mM methyl-β-cyclodextrin (purple), the integrin blocking 
reagent 500 µM K7RGD (yellow), and  250 µM cRGDFK (blue).  
 
 
inhibit the activity of the active endocytosis proteins for a short period of time. For the 
competition assay, K7RGD or cRGDFK was utilized as the integrin-associated blocking 
reagent. The free RGD peptides saturate the available binding sites of the integrin 
receptors on the cell membrane. The uptake of entire series of MSNs decreased with the 
addition of sucrose and methyl-β-cyclodextrin  meaning clathrin and caveolin regulate 
the endocytosis of CA-MSN, linear RGD-MSN, and cyclic RGD-MSN (Figure 7).  
The integrin blocking reagents do not influence the uptake of CA-MSN due to the lack 
of integrin/RGD interactions. The introduction of free RGD ligands caused a minimal 
decrease in the uptake of linear RGD-MSN. Furthermore, a significant decrease of MSN 
internalization was observed in the uptake of cyclic RGD-MSN in the presence of either 
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free cRGDFK or K7RGD. The free RGD ligands with different conformation bind to 
integrin receptors with different affinity.[11] Generally speaking, cyclic RGD ligands bind 
to intergrin receptors more strongly than linear RGD ligands because free linear RGD 
have many random conformations in solution, which decreases the binding strength of 
the integrin.[11] Thus, the concentration of K7RGD used in the competition assay needed 
to be higher than that of cyclic RGD in order to achieve complete saturation of the 
integrin receptors. To determine the effect of free linear RGD concentration on the 
competition assay several different solutions were tested. At 250 µM, no inhibition was 
observed, but when the concentration was increased to 500 µM, the endocytosis 
efficiency of linear RGD-MSN was suppressed. Both linear and cyclic free RGD ligands 
decrease the cellular uptake of all RGD-MSN to some level, indicating that free RGD 
ligands and the RGD-MSN compete for binding to the integrin receptors along the same 
pathway.  
Also, these experiments are evidence that RGD plays an important role in integrin 
recognition and aids in RGD-MSN endocytosis by the cells. If the binding between RGD 
and the integrin occurs, the endocytic pathway is dependent on the integrin association. 
The data shown above in Figure 3 quantifying MSN uptake is obtained from HeLa cell 
studies. Similar results were obtained with the MCF-7 cells were shown on Figure 8. 
Furthermore, those endocytosis studies and competition assays were also tested on 
normal cell line skin fibroblast (Figure 11-12). RGD functionality did not promote the 
uptake efficiency of MSN, and the endocytic pathway was not blocked by free RGDs, 
either linear or cyclic ligands . 
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Fluorescence confocal experiments were performed to determine the location of MSN 
inside HeLa cells (Figure 9). FITC labeled MSN, endosome marker FM-4-64, and 
nuclear staining dye Hoechst 33358 emit at different fluorescence wavelengths and the 
locations of the MSN, endosomes, and nucleus which appear as green, red and blue 
colors, respectively, are observed. The overlays of all the channels gave the images 
shown in Figure 9. The yellow spots observed in Figures 9b and 9c are the result of the 
co-localization of green (FITC-MSN) and red endosome markers. These images indicate 
that after cellular internalization, both the cyclic and linear RGD-MSN remain 
temporarily in endosomes (Figure 9b and 9c), but are released later to the cytoplasm as 
revealed by the abundant green fluorescent spots (Figure 9d and 9e).  
 
Figure 9. Fluorescence confocal micrographs of HeLa cells after a 17 h incubation with 
CA-MSN (a); with linear-RGD-MSN (b); with cyclic-RGD-MSN (c), and after a 40 h 
incubation with linear-RGD-MSN (d); with cyclic-RGD-MSN (e). Most CA-MSN escape 
from the endosomes within 17 h incubation. Linear RGD-MSN and cyclic-RGD-MSN 
are trapped inside the endosomes after incubating for 17 h. After 40 h incubation, linear-
RGD-MSN and cyclic-RGD-MSN escape from the endosomes into the cytoplasm. 
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Figure 10. Fluorescence confocal micrographs of MCF-7 cells after a 17 hr incubation 
with CA-MSN (a); with linear RGD-MSN (b); with cyclic-RGD-MSN (c), and after a 40 
hr incubation with linear RGD-MSN (d); with cyclic-RGD-MSN (e).  
 
Interestingly, microscopy evidence indicated that most CA-MSN escaped from 
endosomes much earlier than both of the RGD-MSN (Figure 9a). A possible explanation 
for this observation is that the RGD functionality caused RGD-MSN to remain in the 
endosomes for a longer period of time compared to CA-MSN because of the binding 
between RGD ligands and the receptor integrins, which would now be present on the 
inside of the endosome (Scheme 1). Integrin trafficking is the process by which integrins 
are endocytosed in vesicles and recycled back to the membrane.[7b, 13] Thus, when RGD-
MSN binds with integrins, the MSN/integrin complex would be transported into the 
endosome. Though the binding of RGD-MSN to the integrin influenced the interaction 
!
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between MSN and endosomes, our results indicate that they still escaped from the 
endosome after 40-h incubation (Figure 9d and 9e). Also, MCF-7 showed the similar 
behavior shown on Figure10.  
 
Scheme 1. The mechanism of endocytosis of cyclic –RGD-MSN (a), 
scanning electron micrograph (b), and transmission electron 
micrograph (c) of RGD-MSN. The scheme is not to scale. 
(a) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(b)                                                     (c) 
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Figure 11. Cellular uptake of MSNs by skin fibroblast cells as a function of the 
concentration of MSN. 
 
Figure 12. The competition assay with the free RGD ligands for  
                                      different MSNs on skin fibroblast cell line  
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Conclusion 
     In conclusion, we demonstrated that cyclic and linear RGD-MSN are internalized by 
human ovarian and breast cancer cells more effectively than CA-MSN through the 
integrin associated endocytotic pathway and undergo endosomal escape after 40 hours. 
Our results also indicate that due to the lack of highly active, specific surface bound 
integrins,[14] some nontumor associated cells do not internalize RGD-MSN via an integrin 
associated endocytic pathway. Specifically, we demonstrated that the uptake of cyclic 
RGD-MSN was more efficient and greatly effected by the competition of free linear and 
cyclic RGD. These results indicate that the uptake efficiency of RGD-MSN is dependent 
upon the conformation of the RGD ligand. This supports the idea that covalent 
functionalization of biomolecules on MSN assists in the design of a system for 
controlling the interface with cancer cells. 
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CHAPTER 3. THE STUDY OF FUNCTIONALITY OF 
MAGNETIC MESOPOROUS SILICA 
NANOPARTICLES ON CELLULAR PROTEIN 
SEQUESTRATION 
 
I-Ju Fang, Kapil Kandel, Igor I. Slowing, and Brian G. Trewyn* 
  
Abstract 
Magnetic mesoporous silica nanoparticles with the desired functionality were 
successfully synthesized.  The MSN materials with the aminopropyl, carboxylic acid, and 
hydrophobic functional groups were compared along with unfunctionalized MSN to 
determine the effect surface chemistry has on protein sequestration.  The normal healthy 
human umbilical vein endothelial cells (HUVECs) and human cervical cancer cells 
(HeLa) were treated with four types of materials to investigate the relationship between 
silica surface functional group and the harvested proteins from both cells. We determined 
that the cell types can be distinguished with the treatment of materials with the different 
functional groups. With varying the surface functional groups, mesoporous silica 
nanoparticles can be used to harvest a diversity of the proteins. Thus, mesoporous silica 
nanoparticles with the designed surface could identify the specific cellular process or the 
travel pathway of excytosed nanoparticles. 
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Introduction 
Mesoporous silica nanoparticle (MSN) materials have been applied as vehicles in the 
drug delivery and chemotherapy fields.1 It is well known that MSN materials are 
internalized by mammalian cells through energy-dependent endocytosis pathways. 
Furthermore, MSN materials can carry cell membrane impermeable drug cargo into 
animal cells and plant cells for the purpose of drug delivery. The biological applications 
mentioned here are based on the advantage of endocytosis, but seldomly exocytosis. 
However, it was recently reported that MSN materials were selectively exocytosed from 
noncancerous mammalian cells and harvested cellular proteins.2 The mechanisms of 
protein adsorption and retention by MSN materials have been reported in several 
publications via electrostatic interactions or hydrogen bonding.3 Cellular proteins can be 
physically adsorbed on to MSN surface and extracted from the pores, recovered and 
analyzed by tandem-MS and electrophoresis. Identification of the harvested cellular 
proteins could aid in determining the dynamic distribution and the path internalized 
MSNs travel through the cell body. Exocytosis of porous nanomaterials opened the door 
for another biotechnological application, the capture and transportation of cellular 
proteins out of cells. By identifying of cellular protein adsorbed on MSN materials, we 
gain information and achieve an understanding of the endocytosis process of MSN 
materials in more detail. These exocytosed MSN materials could be regarded to as 
reporters or messengers for cellular activity. Although many exocytosis studies of various 
nanoparticles such as quantum dots,4 gold nanoparticles,5 carbon nanotubes,6 polymer 
nanoparticles,7 cationic nanoparticles8 and silica particles9 were reported, they mainly 
focused on the mechanism, efficiency, route of exocytoses and the exocytosis 
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dependence on particle size. Because of the network of pores and large pore volume, only 
MSN materials can trap proteins and transport them out of cells. Thus, we attempted to 
study the MSN extracted proteins in more detail. 
The native magnetic MSN materials were found to capture and sequester some cell-
trafficking proteins. Also, iron oxide hybrid silica nanoparticles (Fe3O4@SiO2) have 
recently shown to have applications in the separation of proteins and peptides.10 Because 
Fe3O4@SiO2 are magnetic, an external magnetic field can be utilized for relatively easy 
and rapid collection of the magnetic adsorbents. In addition, the silica composite assists 
in the protection of the iron oxide nanoparticles from agglomeration and oxidation. 
Furthermore, MSN materials can be further modified by organic surface functional 
groups. Thus, magnetic MSN materials with the desired surface functionality have the 
ability to adsorb different types of cellular proteins. We understand that the interaction 
between proteins and the silica surface is controlled by a number of factors including 
pore size, protein characteristics and silica surface chemistries.  
Herein, we aimed to determine what effect surface modification of MSN materials 
have on the adsorption of cellular proteins. A series of 2-d-hexagonally packed, high 
surface area, high pore volume MSN materials with unique organic surface modifiers 
were synthesized, characterized, and analyzed for intracellular protein uptake and 
retention. Three different magnetic MSN surface modifiers were used to make the 
surfaces positive, negative and hydrophobic. They correspond to amino, carboxylic acid, 
and cholic acid functionalized MSN materials, respectively (unfunctionalized MSN was 
used for a control). We chose these three attributes because they could potentially dictate 
the adsorption of proteins into the pores of the MSN materials. The hypothesis is that 
60	  	  
amine functional MSN (positively charged) will capture and retain proteins with an acidic 
pI at physiological pH and vise versa. Similarly, some proteins (i.e. membrane bound)  
are hydrophobic in nature and have a low quantity of charged amino acids on the surface.  
 Healthy human umbilical vein endothelial cells (HUVECs) and cancerous human 
cervical cancer cells (HeLa) were the cell lines chosen for this investigation. Two 
different cell lines were tested because each cell line has variable endocytosis and 
exocytosis efficiencies. The study of both normal and cancer cells can be regarded as a 
simple model for the diseased tissue. Both cell lines demonstrated different endocytosis 
and exocytosis efficiency with the native magnetic MSN materials. We hypothesized that 
the endocytosed MSN materials will sequester different types of intracellular proteins 
depending upon the surface functionality.  
 Large pore magnetic MSN materials were chosen in order to facilitate intracellular 
protein adsorption and capture. The interaction between proteins and MSN surface was 
dictated by controlling the pore size and surface functionality of MSN materials. Large 
pore MSN materials have a highly ordered rigid pore structure, large pore size and 
surface area to accommodate sequestered proteins. Furthermore, the large pore MSN 
materials are made of inert, inorganic material. Their inert inorganic nature results in  
resistance to microbial attack and swelling.11,12  Several publications reported that both 
the surface chemistry and steric conditions in the interior of MSN materials influence the 
extent of protein adsorption. Large pore volume and pore size can reduce the steric 
hindrance effect allowing for protein adsorption. The intracellular proteins sequestered by 
the magnetic MSN materials will be separated by SDS-PAGE (sodium dodecyl sulfate 
polyacrylamide gel electrophoresis) and then subjected to tandem mass-spectrometry 
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analysis (MS/MS) to get the unique fingerprints of the proteins. In this chapter, the study 
of the surface functionality of magnetic MSN materials on intracellular protein 
sequestration is discussed in detail.  
 
Experimental Section 
Chemicals.  All chemicals were used as received without further purification. 
Tetramethylorthosilicate (TMOS) and cholic acid were purchased from Sigma-Aldrich.  
Organic silanes, including 3-aminopropyltrimethoxysilane (APTMS) and 3-
(triethoxysilyl)propylsuccinic anhydride were purchased from Gelest company.  The 
Pluronic 104 triblock copolymer, PEO27PPO61PEO27, was obtained from BASF.  
Synthesis of large pore MSNs:  
 Large-pore MSN materials were prepared by a literature procedure first. A nonionic 
block copolymer Pluronic P104 (7.0 g) was dissolved in an acidic solution of water (164 
g) and aqueous HCl (4 M, 109 g) and stirred at 55 °C for 1 h. Tetramethylorthosilicate 
(TMOS, 10.64 g) was quickly added into the solution at 55 °C. After continuous stirring 
for 24 h, the reaction mixture was moved to a teflon-lined, high-pressure autoclave for 
further hydrothermal treatment at 150 °C for 24 h. The product was isolated by filtration, 
washed with copious amounts of water and methanol, and dried at 80 °C in the air. The 
Pluronic P104 surfactant template was removed from MSN by calcination at 550 °C for 6 
h.  
Synthesis of magnetic large pore MSNs (Fe3O4-MSNs) 
Native magnetic MSN materials were prepared following a literature procedure by 
adding a solution of iron (III) nitrate (Fe(NO3)9H2O) in ethanol (1.26 g in 10 ml) to 
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large-pore MSN materials (0.5 g). The suspension was left to dry in the air at 30 °C with 
constant stirring. The solid was then calcined in air at a heating rate of 10 °C min−1 to 
300 °C. This brownish powder was denoted as Fe2O3-MSNs.  The resulting brownish 
powder was reduced by calcination in a constant flow of H2 (1.67 cm3 s−1) at 300 °C for 5 
h to yield the resulting magnetic MSN materials. This black powder was denoted as 
Fe3O4-MSNs. Superparamagnetic iron oxide nanoparticles were in the interior of the 
mesopores of MSNs. 
Synthesis of amino-functionalized Fe3O4-MSNs (AP-Fe3O4-MSNs) 
Amino-functionalized Fe3O4-MSNs was prepared by grafting 2 mmol APTMS (3-
aminopropyltrimethoxysilane) to the surface of Fe3O4-MSNs (1 g) in refluxing toluene 
(100 mL) for 24 h. The resulting solid was separated by magnetic decantation using 
external neodynium magnet, washed with methanol and dried under vacuum for 24 h. 
Synthesis of succinic acid functionalized Fe3O4-MSNs (SA-Fe3O4-MSNs) 
     The surface of Fe3O4-MSNs (1 g) was grafted with 2 mmol of 3-
(triethoxysilyl)propylsuccinic anhydride in refluxing toluene (100 mL) for 24 h. The 
resulting solid was separated by magnetic decantation using external neodymium magnet, 
washed with methanol and dried under vacuum for 24 h. Finally, succinic acid 
functionalized Fe3O4-MSNs was obtained by stirring the synthesized material in water 
overnight. 
Synthesis of hydrophobic cholic acid functionalized Fe3O4-MSNs (CA-Fe3O4-MSNs) 
Cholic acid-functionalized Fe3O4-MSNs were synthesized by coupling the cholic acid 
(122 mg) to the amino group of amino-functionalized Fe3O4-MSNs (100 mg) through 
EDC chemistry. Because cholic acid is not very soluble in the dichloromethane, ethanol 
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(1 ml) needs to be added to help the dispersion of cholic acid in the 20 ml 
dichloromethane. The introduction of EDC will activate the cholic acid and form the 
intermediate that is amine reactive. Thus, an amide bond is formed between the cholic 
acid and amino-functionalized Fe3O4-MSNs. The resulting solid was washed with water 
and methanol and dried under the vacuum. CA-Fe3O4-MSNs are not extreme 
hydrophobic materials, but have relatively more hydrophobic nature than AP-Fe3O4-
MSNs and SA-Fe3O4-MSNs.  
     The description for the materials used in protein sequestration experiments is 
summarized in Table 1. The structures of functional groups on silica surface are shown in 
Fig 1. 
Table  1. The property and abbreviation of MSN materials 
 
Surface Property at pH 
7.4 
Material Abbreviation 
N.A. Fe3O4-MSNs Fe3O4- MSNs 
Positive charge 
amino-propyl -functionalized- Fe3O4- 
MSNs 
AP-Fe3O4- 
MSNs 
Negative charge 
succinic acid-functionalized- Fe3O4- 
MSNs 
SA-Fe3O4- 
MSNs 
Hydrophobic 
cholic acid-functionalized- Fe3O4- 
MSNs 
CA-Fe3O4- 
MSNs 
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Figure 1. The structure of surface functional groups. 
 
 
Material Characterization:   
Powder X-ray diffraction (PXRD) was performed on a 2-Theta type X-ray 
diffractometer by Rigaku Corporation using Cu-Kα radiation.  The nitrogen gas sorption 
analysis was measured on a Tristar analyzer.  A thermogravimetric analyzer 2950 
manufactured by TA Instruments was used for thermogravimetric analysis (TGA) 
measurement of silica samples.  The samples were heated from room temperature to 
800 °C at ramping rate of 2 °C min-1 in air.  Scanning electron microscopy (SEM) images 
were taken on a Quanta 250 FEG Scanning Electron Microscope made by the FEI 
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Company.  Transmission electron microscopy (TEM) micrographs were recorded on a 
FEI Tecnai G2 F20 STEM working at 200kV.). The ζ-potential of the MSN materials was 
measured in a Malvern Nano HT Zetasizer in triplicate. Suspensions (100 µg mL-1) of 
each of the materials in phosphate buffer (10 mM, pH 7.4) were prepared. Infrared 
spectra were obtained from NEXUS 470 FT-IR. 
Biological Experiment 
Reagents and materials  
HeLa and HUVEC cell lines were obtained from American Tissue Culture Collection 
(ATCC). Trypsin (1×, 0.25%) in 0.1% EDTA without calcium and magnesium was 
purchased from Fisher Scientific.  F-12 K medium was purchased from ATCC company. 
Cell line maintenance 
HeLa cells were maintained in D-10 media in T75 flasks using DMEM (Dulbucco’s 
modified Eagle’s medium) supplemented with 10% equine serum, l-glutamine, penicillin, 
streptomycin, and gentamicin. HeLa cells were split every 2–3 days. HUVEC cells were 
maintained in F-12K media with the growth factor in T-75 flasks. 
Viability test 
Cell viability tests of the HUVEC cells with MSN were studied by Guava ViaCount 
assay (Guava Technologies, Inc.; Hayward, CA). After 4 hour incubation of MSN 
suspension in serum-free media at 37 °C and 5% CO2, the cells were trypsinized, 
centrifuged and resuspended in 1 ml D-10 medium. The cells in media were then counted. 
The cell viability was determined by the Guava ViaCount cytometry assay. 
 
 
66	  	  
Protein-Sequestration Study:  
HUVEC were cultured in T-75 flasks in the F-12K media for several days to attain 
the highest cell density possible and HeLa were seeded in T-75 flasks in the D-10 media 
for one day to get confluency. The media was then replaced by a suspension of magnetic 
MSN materials in serum-free growth media (50 µg ml-1, 50 ml) and incubated at 37 °C 
and 5.5% CO2 for 4 h. The flasks were gently shaken and the supernatant was transferred 
to T-25 flasks with a one-inch-diameter neodymium magnet taped to the exterior of a 
wall. After shaking the flasks, the liquid was removed, and the magnet-immobilized 
particles were washed three times with sterile PBS. For protein electrophoresis, the 
particles were then suspended in a Tris-buffered solution (40 µl, 62 mM, pH 6.8) 
containing 10% glycerol, 5% 2-mercaptoethanol, and 2% sodium dodecylsulfate and 
shaken 2 days at room temperature. The suspension was then heated to 95 °C for at least 
5 min and aliquots (30 µl) were loaded into the wells of a 10–20% Tris–HCl 
polyacrylamide precast gel (10 wells, Bio-Rad Laboratories) and subjected to 
electrophoresis at 135 V for 60 min. The resulting gels were stained with Coomassie-blue 
or silver staining, destained with acetic acid methanol, and photographed by the scanner. 
The resulting bands were cut from the gel, digested in trypsin, and subjected to MS/MS 
analysis. The resulting MS/MS data were used to perform a database search using Mascot 
software.  
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Results and Discussion 
Figure 2. (a) The small angle XRD of MSN materials (a) and high angle XRD of Fe3O4-
MSN (b) 
 
The mesopore arrangements of the materials are elucidated by the powder X-ray 
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diffraction spectra. All the materials showed the typical (100) peak in Figure 2a, which 
indicate that all the materials have hexagonally ordered mesopores. At first, only Fe3O4-
MSN also showed one sharp (100) peak and two additional fine peaks which correspond 
to (110) and (200) peak. The doping of iron oxide nanoparticles in the mesopores did not 
influence the main structure of the hexagonally arranged pores of MSN. However, both 
high order peaks (110 and 200) are absent because of the further organic functionality. 
Often, incorporation of organic functional groups will diminish the fine symmetry of 
mesopores. Overall, the retention of the (100) peak indicates that all the MSN materials 
maintained the symmetric honeycomb shaped mesopores after the addition of surface 
organic functional groups. The high angle XRD pattern of Fe3O4-MSN is shown on 
Figure 2b. The starred peaks refer to the characteristic Bragg angles of the iron oxide 
nanoparticles.10b, 13 
The absorption and desorption nitrogen isotherms of the MSN materials are shown on 
Figure 3. The existence of mesopores was confirmed again by the presence of the typical 
type IV hysteresis commonly associated with mesoporous materials. The coupling of 
organic functional groups on the native Fe3O4-MSN caused a decrease in the surface area 
and pore volumes of the MSN materials. The functional groups also have their own 
dimension; as a result, the diameter of the mesopores became smaller. The values of 
surface area and pore size for the materials were illustrated on Table 2. Even after surface 
immobilizing the organic functional groups all the MSN materials have a surface area 
and pore size large enough to accommodate many proteins. For AP-Fe3O4-MSN, the 
surface area is similar to the native Fe3O4-MSN. For SA-Fe3O4-MSN, surface area of 
MSN material dropped significantly because of the space hindrance of succinic acid 
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functional groups. CA-Fe3O4-MSN showed the lowest surface area and pore size because 
the bulky cholic acid occupies a greater amount of space in the mesopores than the other 
two functional groups. This being said, however; all of the MSN materials still had 
adequate space to trap the intracellular proteins.  
The additional characteristic data shown in Table 3 further confirms successful 
surface functionalization. Organic content of the MSN materials were obtained from 
TGA analysis. After further organic functional group derivatization, AP-Fe3O4-MSN, 
SA-Fe3O4-MSN and CA-Fe3O4-MSN have adequate aminopropyl, carboxylic acid and 
aminopropyl cholic acid functional groups on the MSN surface, respectively. The surface 
charge measurements were performed in PBS at physiological pH. The surface charge of 
native Fe3O4-MSN was negative due to a large concentration of nonprotonated silanols 
on the surface and the surface charge of AP-Fe3O4-MSN was positive because of the 
surface bound amino groups. The coupling of cholic acid groups to the primary amines 
Figure 3. The sorption isotherm of iron oxide doped mesoporous silica nanoparticles. 	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caused the surface of CA-Fe3O4-MSN to become slightly negative. SA-Fe3O4-MSN 
became more negative resulting from the grafting of propylsuccinic acid on the surface. 
Also, SA-Fe3O4-MSN and CA-Fe3O4-MSN showed the carbonyl peaks during infrared 
analysis that correspond to the carboxylic acid and amide bond.  
Table 2. The values of surface area and pore size of iron oxide doped mesoporous   
                      silica nanoparticles. 
Material Surface area (m2 g-1) 
Pore size 
(nm) 
Fe3O4-MSN 254 9.1 
AP-Fe3O4-MSN 229 9.0 
SA-Fe3O4-MSN 176 9.1 
CA-Fe3O4-MSN 102 5.2 
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Table 3. Characteristic data of the series of MSN materials including the percent by 
weight of the organic functional groups, the surface charge, and the 
wavenumber value of the infrared peaks corresponding to the surface 
carbonyl groups of materials. 
Material Organic content (%) 
Surface charge 
(mV) 
Carbonyl peaks 
(cm-1) 
Fe3O4-MSN N.A. -18.8 N.A. 
AP-Fe3O4-MSN 13.67 +20.1 N.A. 
SA-Fe3O4-MSN 13.89 -24.8 1720 
CA-Fe3O4-MSN 23.71 -3.7 1647 	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Figure 4. The infrared spectra of MSN materials. The infrared spectrum of Fe3O4-MSN 
AP-Fe3O4-MSN, SA-Fe3O4-MSN and CA-Fe3O4-MSN are showed in blue, red, green, 
and light blue, respectively. 
The full infrared spectra of materials were shown in Figure 4. Fe3O4-MSN does not 
have any specific identifiable peak; however, AP-Fe3O4-MSN, SA-Fe3O4-MSN and CA-
Fe3O4-MSN showed their characteristic peaks for the identification of surface organic 
functional groups. For example, they have the similar peaks around 2856 and 2936 cm-1 
for the alkyl groups. In addition, SA-Fe3O4-MSN has a peak at 1720 cm-1 for the 
carboxylic acid and CA-Fe3O4-MSN has an amide bond peak at 1647 cm-1. 
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The morphology of the MSN materials can be observed in Figure 5. Fe3O4-MSN 
materials are dish-like hexagons that are roughly 500 x 250 nm in size. Clearly, iron 
oxide nanoparticles can be observed doped inside the mesopore channels. In some small 
fields, the parallel channels can be observed. Post-synthesis grafting of organic functional 
groups has demonstrated repeatedly to maintain the MSN morphology and size14; thus, 
all the materials have the same morphology as Fe3O4-MSN. 
For protein sequestration studies, both HUVEC and HeLa cells were treated with 
MSN materials with the desired functionality at 50 µg mL-1 for 4 h. Optical microscopy 
analysis results indicate that the iron oxide doped MSNs were full of internalized by the 
cells. The viability of both cell types with the entire series of materials was measured by 
Quava Via tests (Figure 6). HeLa and HUVEC cells demonstrated biocompatibility with 
all four tested MSN materials. The cytotoxicity tests indicate that the surface organic 
functional groups were nontoxic to the cells and demonstrated the same level of 
(a)                                                    (b) 
Figure 5. Scanning electron microscopy image (a) and transmission electron 
microscopy image (b) of Fe3O4-MSN	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biocompatibility as the native magnetic MSN. Both cell lines maintained cell viability 
when incubated with iron oxide MSN suspensions at a concentration of 50 µg mL-1. 
SDS-PAGE was used for the separation of harvested intracellular proteins; the results  
are shown on Figure 7. The ladder is a SDS-PAGE standard for proteins with molecular  
 
Figure 6. The viability of HUVEC (top) and HeLa (bottom) 
with the treatment of the desired MSN materials	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weights from 6.9 to 200 kDa. Fe3O4-MSNs with the different surface functional groups 
have the ability to adsorb and retain proteins. When the surface functionality changed, the 
amounts and types of proteins captured and sequestered varied among the MSN materials. 
     For example, Fe3O4-MSN captured and sequestered three proteins that matched with 
annexin A2, cytoplasmic actin-1, and α-actin-4.2 AP-Fe3O4-MSN, SA-Fe3O4-MSN and 
Figure 7. The SDS-PAGE images of extracted proteins from HUVEC	  cells	  
(top) and HeLa cells (bottom). UN, AP, SA and CA refer to Fe3O4-
MSN, AP-Fe3O4-MSN, SA-Fe3O4-MSN and CA-Fe3O4-MSN, 
respectively.	  The	  ladder is a	  protein	  molecular weight marker. 
Lysate is from	  cellular protein solution upon the treatment of cells	  with	  10	  %	  SDS. 
  1 
  2 
 3 
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CA-Fe3O4-MSN harvested six, two and three proteins from live HUVECs, respectively. 
When the concentration of protein is greater, the bands appear darker. Thus, even though 
the MSN materials have affinity for the proteins with the similar molecular weight, the 
concentration of harvested proteins are obviously different. Most extracted proteins were 
related to the concentrated protein bands of cell lysate. Furthermore, Fe3O4-MSN, AP-
Fe3O4-MSN, SA-Fe3O4-MSN and CA-Fe3O4-MSN harvested seven, seven, two and three 
proteins out of HeLa cells within the detection limit of SDS-PAGE, respectively.  
In summary, Fe3O4-MSNs with non-, aminopropyl, carboxylic acid, or hydrophobic 
cholic acid demonstrated the sequestration of intracellular proteins. Proteins were 
attracted to the Fe3O4-MSN with specific functional groups at different strengths based 
on the interaction between proteins and the silica surface. Although CA-Fe3O4-MSN had 
smallest measured pore size, it showed selectivity for sequestering intracellular proteins. 
Selectivity occurred between materials and cell lines. Different materials can carry out 
different types of proteins on the same cell type. The proteins extracted by the different 
materials between cell lines showed the distinct patterns. The patterns shown by cells 
could be regarded as a fingerprint for cell type. With the co-treatment of materials, the 
Table 4.	  Proteins	  extracted	  from	  MSN	  materials that were exocytosed by HUVEC or 
HeLa cells. The proteins were subjected to the MS/MS analysis. The resulting 
fingerprint spectra were compared to protein databases library using Mascot 
software. Matches with Mowse scores higher than 27 are expected to be 
identical or highly homologous (p < 0.05) to the corresponding proteins. 
Band Molecular weight [kDa] Protein UniProt Accesion Number 
Mowse 
Score 
1 112835 ASAP2 O43150 31 
2 12947 RL30 P62888 35 
3 83398 CNOTA Q9H9A5 35 
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cell identification can be accomplished. 
Some proteins extracted from exocytosed MSN were subjected to MS/MS analysis. 
Most protein bands cannot be identified correctly because the amount of protein was too 
dilute or the samples were contaminated by keratin during preparation, which is abundant 
in hair and fingernails. The three protein bands that were identified are summarized on 
Table 4. First, ASAP2 protein is localized in the Golgi and in the plasma membrane.15 
This protein functions to control vesicle budding. In addition, it is involved in the 
regulation of vesicular transport. Secondly, RL30 is ribosomal protein.16 Ribosomes are 
the organelles that catalyze the synthesis of cellular proteins. The protein is located in the 
cytoplasm. Finally, CNOTA is a protein (pI 7.95) located in the cytosol.17 It is involved 
in many biological processes such as RNA metabolic process and mRNA metabolic 
process. Thus, the MSN with a variety of functionality can access the ribosome or Golgi 
in the cytoplasm. We anticipate that these designed MSN materials can be used to design 
drug delivery or catalysis systems targeted to specific organelles.  
Conclusion 
The synthesis and characterization of a series of iron oxide MSN materials with non-, 
aminopropyl, carboxylic acid and hydrophobic functional groups was successful. In fact, 
MSN materials with different functionality can harvest different types of proteins and 
showed the sensitivity and selectivity between both HUVEC and HeLa cells. They could 
be used as a fingerprint to distinguish the cell types. Also, they can access some 
organelles that play the role in the catalysis, metabolism, and trafficking. This will 
strengthen the potential applications of MSN materials in biological fields. 
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CHAPTER 4. THE PROGRAMMABLE ENDOCYTOSIS 
BEHAVIOR OF MESOPOROUS SILICA 
NANOPARTICLES 
 
I-Ju Fang, Brian G. Trewyn* and Victor S.-Y. Lin 
 
Abstract 
     The protein, bovine serum albumin (BSA), is noncovalently linked to the external 
surface of biotin functionalized mesoporous silica nanoparticle (MSN) materials through 
the avidin-biotin bridge with a cleavable disulfide ligand. This system was designed to 
determine how the biomolecule functionalization on MSN surface influences the 
endocytosis efficiency of mesoporous silica nanoparticles toward cancer cells. We 
focused on developing a method for dual layer protein deposition on MSN surface to 
control the endocytosis behavior toward cells. These materials were treated with DTT 
and the enzyme, trypsin, in order to examine the effects of thiol reducing antioxidants and 
proteases on the endocytosis behavior of cells. 
     Avidin immobilized MSN materials have greater affinity for biotinylated (BSA-B) 
than native MSN (unfunctionalized). Once BSA is functionalized on the MSN surface, it 
shows the opposite charge behavior for avidin-immobilized MSN. Because both proteins 
have opposite charges and different size, they change surface property of MSN 
immediately, furthermore change the endocytosis efficiency of MSN toward cancer cells 
quickly. As a result, we can manipulate the endocytotic behavior of MSN by simply 
linking biotinylated biomolecules on MSN. Once the protein immobilized MSN materials 
encounter a reducing reagent or protease the release of proteins from the MSN surface is 
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triggered, the endocytotic efficiency will be changed. Finally, the cellular endocytosis 
efficiency of MSN materials can be easily manipulated by changing identity of the 
surface bound protein, the reducing reagent and protease.  
 
Introduction 
     The construction of functional and organized biomolecule-containing multilayer films 
is one of the focal subjects in biomaterials and biotechnology. There are mainly two 
principles for the construction of biomolecule-containing multilayers.4 One method is 
based on the electrostatic attraction between opposite charges.5,6 The formation of 
multilayer assemblies using this method was first realized by consecutively alternating 
adsorption of anionic and cationic polyelectrolytes. This technique has been utilized to 
construct multilayer protein-containing films by the adsorption of oppositely charged 
polyelectrolytes and proteins. However, great effort is needed to control the nonspecific 
adsorption between proteins and polyelectrolytes. Furthermore, this electrostatic 
adsorption method is not very suitable for all protein molecules because solution pH 
value and ionic strength can affect the bio-multilayers obtained by this method. 
The other way to construct protein multilayers with ordered structure is to employ 
the biological specific interactions such as antibody-antigen and biotin-avidin.7,8 For 
example, the multilayer can be constructed by means of avidin-biotin interaction. The 
remarkable strength of the interaction between the egg-white avidin and the vitamin 
biotin has attracted a great deal of attention for more than 50 years. This unique property 
is the main reason that the avidin-biotin system has been frequently used in many 
biotechnological applications. Owing to the high affinity and stable nature of the 
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resulting complex, the avidin-biotin system is currently widely used to label biomolecules 
with dyes, fluorophores, enzymes, etc.9 This type of interaction is one of the strongest 
known non-covalent that includes binding between proteins and ligands. The binding 
constant between avidin and biotin analogs is 5.0 x 10 15 M-1.2,3 The bond formation 
between biotin and avidin is very rapid and once formed, is unaffected by wide extremes 
of pH (2-13), temperature (up to 120 °C), organic solvents and other denaturing agents.10 
Moreover, avidin can also bind compounds shown on Table 1 to form metastable 
complexes.11 Thus, the biomolecule containing multilayer can be constructed by taking 
advantage of the stable avidin-biotin complex or other metastable avidin-biotin analogue 
complex.   
    The multilayer assemblies stated above could be applied to MSN surface as a cap in 
drug delivery systems or target marker for endocytosis study of MSN materials. The 
avidin-biotin interaction was chosen as a linker to construct dual layers on the MSN 
surface. This work presents a unique method for the design of multicapping proteins on 
the surface of MSN materials through small biotin ligands. Avidin is regarded to as a 
universal receptor for biotinylated compounds or proteins.12 For instance, avidin can be 
conjugated with BSA-B and biotinylated IgG, and antibody.12-14 Avidin and BSA-B were 
used to demonstrate the feasibility of attaching dual layers of proteins on the MSN 
surface. Initially, biotin functionalized MSNs are synthesized via amidation of biotin 
NHS ester with aminoprypyl groups on MSN. On the surface of biotin functionalized 
MSNs, protein multilayers made up of avidin and BSA-B are constructed via avidin-
biotin bond. Avidin will form a stable complex with the BSA-B on biotin functionalized 
MSNs by taking advantage of an electrostatic force of attraction, hydrogen bonding, and 
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avidin-biotin interaction. The bioaffinity exists only between avidin and BSA-B, but not 
native BSA.14 
Avidin (MW 68,000 Da) is ellipsoidal protein, with dimensions of 5.6 nm x 5.0 nm 
x 4.0 nm.15 Avidin has be used as building blocks for the construction of multilayer 
deposition because the dihedral D2 molecular symmetry of the avidin homotetramer 
positions two pairs of biotin binding sites on opposite faces of the protein, which opens 
possibilities to construct multilayer architectures.16 Simply speaking, these four binding 
sites are located in pairs on either side of protein molecule. Thus, upon binding to a 
biotin-analogue ligand (Figure 1) via both binding sites on one face of the protein, the 
binding sites on the opposite face are accessible to other biotin analogue. Totally, avidin 
contains four identical binding sites to biotin. Binding between avidin and biotin is an 
Figure 1. Biotin analogue1 
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irreversible process. Avidin is extremely stable to thermal denaturation. The molar 
extinction coefficient of avidin is 97400 M−1cm−1 at 280 nm. Because the isoelectric 
point of avidin is pH 10.5, it is the basic protein contains net positive charge at a 
physiological pH. Although	   avidin	   was	   used	   on	   MSN	   surface	   as	   a	   cap	   in	   a	   drug	  delivery	  system17,18,	  no	  study	  related	  to	  the	  endocytosis	  of	  avidin—MSNs	  has	  been	  reported. Moreover, the most important thing is that avidin can bind to sugar-binding 
lectin, which highly expressed on tumor cell surface. Lectin helped the accumulation of 
avidin in cancer cells because of the binding between lectin and avidin.19,20 Avidin could 
improve the cellular accumulation of MSN materials in HeLa cells potentially.	  	  	  	  	  
ligand The binding constant of ligand to avidin (M-1) 
biotin 1 x 1015 
dethiobiotin 5 x 1013 
2-iminobiotin 
2.9 x 1010 in the basic solution 
103 in the acidic solution 
lipoic acid 1.4 x 106 
2-(4-
Hydroxyphenylazo)benzoic 
acid (HABA) 
1.7 x 105 
	  	  	  
Table 1. The binding ability of ligand to avidin.2,3	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     Biotin (MW 244 Da, vitamin H) forms a very stable complex with avidin. Avidin also 
binds analogue compounds of biotin such as lipoic acid, desthiobiotin, 2-iminobiotin and 
2-[(4-hydroxybenzene)azo]benzoic acid (HABA) (Figure 1). There are many differences 
in the bioaffinity between biotin and biotin-analogue compounds to the binding protein, 
avidin. The binding site and source of strong interaction of avidin for biotin is a 
collection of hydrogen bonding between biotin and amino acid residues.21,22 Biotin is 
completely buried in the binding sites of avidin. The fused biotin-ring system forms a 
network of hydrogen-bonding interactions. The ureido moiety of biotin in the bound state 
forms hydrogen bonds to five residues, three for the carbonyl oxygen and one for each -
NH group. These five hydrogen bonds act cooperatively; as a result, it leads to 
stabilization that is larger than the sum of individual hydrogen-bonding energies. In the 
avidin–biotin complex, one of the carboxylate O atoms forms three hydrogen bonds with 
Thr38 O, Ala39 N and Thr40 N and the other forms two hydrogen bonds with Ser73 O 
and Ser75 O.21 
Bovine serum albumin (MW 66430 Da) is also ellipsoidal protein with dimensions 
of 14.0 nm x 4.0 nm x 4.0 nm. The commercial availability of albumins at high purity 
(generally ≥96%) and at low cost together with their high water solubility, is favorable 
for their use as preferred modification platform. Albumins with relatively high lysine 
residues are desired because the primary amine on lysine amino acids are often used to 
derivatize proteins with biotin, BSA has 59 lysine residues. The pI of BSA is 4.7, so BSA 
has the electrostatic force of attraction for avidin at pH 7.4. Extinction coefficient of BSA 
is 0.667 ml mg-1 cm-1 at 280 nm. It was reported that there were on average 3.5-9 biotin 
analogue ligands bound to each BSA molecule through the derivative of lysine residues 
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of BSA.11,12,14 Avidin, being a tetramer, cross-links BSA via its covalently bound ligands, 
biotin (at least two biotins per BSA). Thus, it is possible that BSA-B can bind up to 4 
avidins, and the multilayers made up of BSA-B and avidin will be constructed. Herein, 
BSA can be regarded as a model biotinylated-macromolecule. BSA does not have any 
interaction with bioitn.23 The synthesis and design of this work could be applied to 
biotinylated biomolecule or avidin-bound protein.24-26 Basically, any macromolecule can 
be linked to MSN through this interaction. Once a biomolecule is immobilized on the 
MSN surface by an avidin-biotin bridge, the endocytosis behavior of MSN will be 
changed with the nature of macromolecule. Furthermore dual-layer protein immobilized 
MSN materials possess the cleavable disulfide bond between surface biotin and silica 
surface. Thus, the endocytosis of protein immobilized MSNs could be governed by the 
disulfide reducing reagent and the protease. The dithiothreitol (DTT) and trypsin were 
chosen to mimic the biological environment that protein immobilized MSN will 
encounter. If this type of protein (macromolecule) capped mesoporous silica nanoparticle 
material can be applied as a drug delivery vehicle, the endocytosis efficiency and the 
percent of intracellular distribution of the release system could potentially be finely-
controlled. 
 
Experimental Section 
Chemicals.  Avidin , BSA, fluorescein	  isothiocyanate	  isomer	  I, tetraethyl orthosilicate 
(TEOS), trypsin, dithiothreitol and	   N-­‐cetyltrimethylammonium	   bromide were 
purchased from Sigma-Aldrich.	   Organic silanes, 3-aminopropyltrimethoxysilane 
(APTMS) was purchased from Gelest. NHS-Biotin and Sulfo-NHS-SS-Biotin were 
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obtained from Thermoscientific.  
 
Synthesis of MSNs 
     The MSN materials were synthesized by the co-condensation method.27 First, N-
cetyltrimethylammonium bromide (CTAB, 1.00 g, 2.74 mmol) was dissolved in 480 mL 
of nanopure water. A solution of sodium hydroxide (2.00 M, 3.50 mL) was introduced to 
the CTAB solution at 80 degree. Tetraethoxysilane (TEOS, 5.00 mL, 22.4 mmol) was 
added dropwise by syringe pump to the surfactant solution at a rate 30 ml/hour under 
vigorous stirring. Also, the FITC isomer reacted with APTMS for 2 h in methanol in 
advance, and then this solution was added in to MSN suspension to mix well. The 
solution was allowed to react for 2 h to produce a white precipitate, followed by filtration 
and washing with copious amount of water and methanol to yield an as-made MSN. The 
resulting as-made MSN were dried under high vacuum overnight. 
Synthesis of amino group functionalized-MSN (Amine-MSN): 
     The MSN material is further functionalized with 3-aminopropyltriethoxysilane 
coupling reagent through a post synthetic grafting method. Typically the as-made MSN 
(1 g) was refluxed with 3-aminopropyltriethoxysilane (1 mmol) in the 80 ml of 
anhydrous toluene at 110 °C, followed by washing with deionized water and methanol. 
Then, dried under high vacuum to yield as synthesized amino functionalized MSN 
(Amine-MSN).  
Biotin-conjugated of amino group functionalized-MSN with cleavable disulfide 
bond (B-SS-Amine-MSN)  
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     Amine-MSN (0.55 g) was dispersed in 20 ml PBS buffer and then followed by an 
introduction of biotin-NHS ester solution  (Sulfo-NHS-SS-Biotin (125 mg) dissolved in 2 
ml DMSO) and stirred at room temperature overnight. To remove the surfactant template 
(CTAB) from synthesized B-SS-AmineE-MSN, the B-SS-AmineE-MSN (1.0 g) was 
refluxed in an acidic methanolic solution (1.00 mL of concentrated HCl in 100.00 mL 
methanol) at 60 °C for 6 h. The extracted material was filtered, extensively washed with 
deionized water and methanol, and dried under high vacuum to yield the biotin grafted 
MSN. 
The immobilization of protein on B-SS-Amine-MSN surface 
1. Biotinylated Protein (ex. BSA-B) 
 Biotin N-hydroxysuccinimide ester dissolved in dimethyl sulfoxide (DMSO, 0.50 ml) 
was added to a solution of proteins dissolved in phosphate buffered saline (pH 7.4), and 
stirred overnight. The solution was dialyzed in PBS, containing 5% DMSO, for 1 day. 
Following dialysis with Milli-Q water, a white product was obtained by freeze-drying. 
The biotins ligands bound to BSA were quantified via the HABA assay. In this work, one 
BSA has 5.3 biotin ligands averagely by HABA assay. 
2. Protein immobilized MSN  
     Avidin–PBS solution (1.0 mg in 1 ml, pH 7.4) and biotinylated protein–PBS solution 
(3 mg in 3ml, pH 7.4) were separately prepared. First, B-SS-Amine-MSN was dispersed 
into the avidin solution, stirred overnight at room temperature. Following stirring, the 
biotinylated protein–PBS solution was added to the MSN suspension. The solution was 
centrifuged and washed by PBS three times to get rid of excess proteins to yield the 
protein immobilized MSN via biotin-avidin linkage. Avidin immobilized on B-SS-
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Amine-MSN is called Avi-B-SS-Amine-MSN. BSA-B bound to Avi-B-SS-Amine-MSN 
through biotin linker is called BSA-B-Avi-B-SS-Amine-MSN. 
Assay for ligand content 
     To quantify the ligand loading, a displacement test for avidin-HABA complex with 
biotin-related compounds was conducted. The ligand to BSA ratio in the BSA-B 
conjugate is determined by a HABA (2-(4-Hydroxyphenylazo)benzoic acid) 
displacement assay. The ligand content will be determined by gradually adding a small 
portion of BSA-B conjugate to phosphate solution containing avidin and HABA with the 
certain concentration. (The concentration of HABA is much greater that that of avidin). It 
is known that HABA exhibits a strong absorption at 500 nm when complexed with avidin 
while absorbance of free HABA is negligibly small at this wavelength.20,28-31 Addition of 
HABA in excess to avidin under conditions where almost all of it is bound gives a new 
absorption band at 500 nm and a color change from yellow to red (ε500 increases from 600 
to 34500 M−1cm−1). At the same time the intensity of the 348 nm band of HABA 
decreases. These changes are reversed by the addition of biotin to avidin. A small amount 
of biotin or biotin analogue was added into the HABA-avidin solution. The absorbance at 
500 nm decreases rapidly upon addition of biotin or biotin analogues, suggesting that the 
bound HABA is displaced by biotin or biotin analogues since the binding constant 
between biotin or biotin analogues and avidin is much higher than that for HABA-avidin 
complexation (ca. 1.7 x 105 M-1 in solution). The change in absorbance at 500 nm was 
measured after successive additions of standard biotin analogue solutions with a 
micropipet until no further change occurred. Biotin or biotin analogues displaces HABA 
to an extent dependent on their binding constants. 
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The HABA content is calculated from the HABA specific absorbance at 348 nm. 
The protein concentration is calculated from the absorbance at 280 nm, using a series of 
BSA standards. As a result, the ligand content of the protein is calculated. 
Material Characterization:   
     Powder X-ray diffraction (PXRD) was performed on a 2-Theta type X-ray 
diffractometer using Cu-Kα radiation.  The nitrogen gas sorption analysis was measured 
on a Tristar analyzer.  A thermogravimetric analyzer 2950 manufactured by TA 
Instruments was used for thermogravimetric analysis (TGA) measurement of silica 
samples.  The samples were heated from room temperature to 800 °C at ramping rate of 
2 °C/min in air.  Scanning electron microscopy (SEM) images were recorded on a Quanta 
250 FEG Scanning Electron Microscope made by the FEI Company. The ζ -potential of 
the MSN materials was measured in a Malvern Nano HT Zetasizer in triplicate. 
Suspensions (100 µg mL-1) of each of the materials in phosphate buffer (10 mM, pH 7.4) 
were prepared.  
 
Biological Experiment 
Reagents and materials  
     HeLa cell line was obtained from American Tissue Culture Collection (ATCC). 
Trypsin (1×, 0.25%) in 0.1% EDTA without calcium and magnesium was purchased 
from Fisher Scientific.   
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Cell line maintenance 
     HeLa cells were maintained in D-10 media in T75 flasks using DMEM (Dulbucco’s 
modified Eagle’s medium) supplemented with 10% equine serum, l-glutamine, penicillin, 
streptomycin, and gentamicin. HeLa cells were split every 2–3 days.  
Fluorescence confocal microscopy measurements 
     To study the endocytosis of MSN materials, fluorescence confocal microscopy was 
employed. Coverslips (22 mm2) were cleaned with surfactant (Contrad 70), nanopure 
water (3×), and 100% methanol, and dried overnight and followed by polylysine coating. 
The polylysine coated coverslips were placed on the bottom of the wells of 6-well plates 
and incubated with 3.0 mL of standard D-10 growth media. Two samples were prepared 
for the confocal microscopy study. First, HeLa (1.0×105 cells mL−1) were grown for 30 h 
on the coverslips. After 30 h cell growth, the cells were incubated with 2 µg mL−1 MSN 
materials with endosome marker FM 4-64, and grown for an additional 13-17 h. 
Afterwards, the growth media was removed, the cells were washed with PBS (2×), and 
the cells were then reincubated with Hoechst 33258 for 15 min to stain the cell nucleus. 
These coverslips were removed and fixed to glass slides with adhesive. Blue nuclei stain 
was observed by exciting the cells with a UV laser at 340 nm. The green fluorescent from 
MSN (FITC prelabeled) particles internalized by the HeLa cells was visualized by 
excitation at 488 nm with an argon laser. The red fluorescent endosome marker was 
excited at 515 nm. 
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DTT treatment     Materials (10 mg) were treated with DTT at 50 mM overnight. 
Materials were washing by water to remove chemicals adsorbed on surface, and then 
dried under vacuum. 
The digestion of protein immobilized by trypsin     Materials (10 mg) were treated with 
trypsin at 1 mg ml-1 overnight at 37 °C. Materials were washing by water to remove 
peptides adsorbed on surface, and then dried under vacuum. 
 
 
Results and Discussion 
 
 
 
 
 
 
 
 
 
Figure 2. The small angle XRD (a) and the nitrogen sorption isotherm of B-SS-Amine-MSN. 	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Figure 3. 13C solid-state CPMAS NMR spectra of the B-SS-Amine-MSN. The      
characteristic peaks are identified above.
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Table 2. The zeta potential values of the MSN materials. 
Material Zeta potential (mV) 
MSN -13.1 
Amine-MSN +10.9 
B-SS-Amine-MSN -7.2 
Avi-B-SS-Amine-MSN +11.9 
BSA-B-Avi-B-SS-Amine-
MSN -27.3 
 
     The basic mesoporous characteristic properties of B-SS-Amine-MSN were shown on 
Figure 2. B-SS-Amine-MSN showed the typical (100) peak indicating the hexagonal 
arrangement of mesopores in Figure 2a and a type IV isotherm showing the presence of 
mesopores in Figure 2b. Also it has a surface area of 706 m2 g-1 and pore size of 2.3 nm. 
The structure of organic functional groups of B-SS-Amine-MSN and the identification of 
13C peaks were shown on Figure 3. The existence of the amide bonds indicated the 
coupling of biotin ligands was successful and the biotin ligands were linked to the surface 
bound aminopropyl groups covalently. Furthermore, every surface modification changed 
the surface potential showed on Table 2. Unfunctionalized MSN is negative (-13.1 mV), 
but the aminopropyl grafting reversed the surface charge to positive. The further amide 
bond formation of amine-MSN with biotin ligands compensated the positive charge from 
aminopropyl groups. In addition, because avidin and BSA are positive and negative, 
respectively, at pH 7.4, the direction of surface charge of B-SS-Amine-MSN would 
change toward the native charge of proteins immobilized. For example, the deposition of 
avidin and BSA on MSN surface gave opposite surface charges. 
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     The amount of biotin, avidin, and BSA on BSA-B-Avi-B-SS-Amine-MSN were 
quantified by TGA and UV-Vis in Table 3. For TGA measurements, the organic content 
of biotin or proteins was calculated by measuring the delta of organic weight loss before 
and after the corresponding synthesis steps. Thus, BSA-B-Avi-B-SS-Amine-MSN has 
abundant surface biotin ligands for the affinity of avidin. Although BSA-biotin can be 
bound to avidin, the loading density of BSA-biotin was smaller than that of avidin due to 
the size of BSA and limited external surface of the MSN materials. The organic content 
values determined by TGA were consistent with the protein content determined by UV-
Vis. On the silica surface, the deposition of avidin was greater than that of BSA-biotin. 
The quantity of protein immobilized on the MSN surface was determined by calculating 
the protein concentration in the solution before and after the deposition of proteins on the 
MSN. Furthermore, the biotin density was determined by the HABA assay. The HABA 
assay reports the amount of biotin that remains an affinity to avidin. B-SS-Amine-MSN 
has surface biotin in 25.5 µmol g-1. 
 
 
 Organic content (%) by 
TGA 
Protein content (µmol g-1) 
by UV-Vis 
Aminopropyl biotin 29.9 N.A. 
Avidin 11.8 4.76 
BSA 2.35 2.41 
Table 3. The quantitative analysis of BSA-B-Avi-B-SS-Amine-MSN. 
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     The size and morphology of Avi-B-SS-Amine-MSN and BSA-B-Avi-B-SS-Amine-
MSN were observed on Fig. 4. Both materials have spherical morphology and the range 
of particles size ranged from 100 nm to 250 nm.  
 
MSN Thiol density (µmol g
-1) 
with DTT treatment 
Avi-B-SS-Amine-MSN 92.0 
BSA-B-Avi-B-SS-Amine-MSN 100.8 
B-SS-Amine-MSN 90.5 
 
 
 
 
Figure 4. Scanning electron micrograph of Avi-B-SS-Amine-MSN (a) and BSA-B-
Avi-B-SS-Amine-MSN (b). 	  
(a)                                                                  (b) 
Table 3. The efficiency of DTT for the MSN materials.	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     When this MSN material is injected to animal tissue, they could encounter cell-
produced antioxidants (ex. glutathione (GSH) or dihydrolipoic acid (DHLA)) and 
proteases. This disulfide reducing and protein digestive natural environment were 
mimicked by treating the MSN materials with DTT and trypsin. The disulfide bond is 
cleavable by DTT. The efficiency of DTT was tested on the three MSN materials 
summarized on Table 3. The thiol density was determined by a previously published 
method.32 After incubation with DTT reagent, all the three MSN materials have plenty 
surface thiol groups from 92-100 µmol g-1. Thus, DTT can cleave the disulfide bond on 
MSN surface to reveal the free thiol groups with or without the immobilized proteins. In 
addition, DTT can reduce the disulfide bonds formed between cysteine residues that are 
part of both protein sequences33,34, and Avi-B-SS-Amine-MSN and BSA-B-Avi-B-SS-
Amine-MSN gave rise to more thiol functional groups because a few protein molecules 
physically adsorbed on DTT treated MSN materials. 
     The effect of protease on cellular uptake of protein immobilized MSN materials was 
also examined. The protease, trypsin, was chosen as the digestive protein for the 
experiment. Trypsin has previously been demonstrated to digest avidin on the MSN 
surface.18 The surface charge and the cellular uptake of MSN materials were summarized 
on Figure 5. Each material has its own cellular uptake and surface charge. The change in 
surface charge refers directly back to the change in MSN surface functionality. For 
example, the avidin deposition on B-SS-Amine-MSN gave rise to the positive surface. 
After the treatment of DTT or trypsin, the positive surface charge on Avi-B-SS-Amine-
MSN changed to a negative charge due to the disappearance of avidin. Also, BSA-B-A-
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B-SS-Amine-MSN demonstrated similar behavior. Generally speaking, positively 
charged MSN materials are internalized more by cells because positive nanoparticles 
have an electrostatic attraction to the negatively charged cell membrane.  Avi-B-SS-
Amine-MSN has the highest cellular uptake, which corresponds to the highest positively 
charged surface. BSA-B-A-B-SS-Amine-MSN has the most negative surface charge and 
resulted in the lowest endocytosis efficiency. Before and after the DTT or trypsin 
treatment, the surface charge values of the MSN materials are easily distinguishable. As a 
result, their cellular uptake values change along with the surface charge. For example, if 
the treatment promotes the occurrence of the positive surface, the endocytosis efficiency 
will improve. The span for the adjustment of cellular efficiency ranged from 8 to 40 µg 
ml-1, the surface charge of this series of MSN materials ranges between 11.9 and -27.3 
mV. 
    Avidin or BSA could also be physically adsorbed onto the MSN surface causing a 
change in surface charge and endocytosis efficiency. Control experiments were 
performed with MSN containing physically adsorbed proteins. The effect of trypsin on 
these control MSN materials was investigated. Avidin or BSA adsorption will change 
surface charge according to the protein native charge. With the treatment of trypsin, the 
surface charge changed. However, such a change of surface charge did not play an 
important role on the cellular uptake of materials. No significant difference was observed. 
This could be related to the lower loading density of protein on native MSN surface than 
on the MSN materials functionalized with biotin moiety. The loading amount was 1.26 
and 0.82 µmol g-1 for avidin and BSA, respectively. The change of surface charge and the 
cellular uptake of this MSN material are 14.5 mV and 6 µg ml-1, respectively. 
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      Endocytosis of MSN internalized by HeLa was observed by the confocal fluorescence 
microscopy in Figure 7. Blue, red, and green colors represent the nuclear, endosome 
marker FM4-64, and free MSN that escaped from endosome, respectively. The 
colocalization of endosome marker and MSN are observed as the yellow spots in Figure 7, 
this yellow color comes from the overlap of red and green (endosomes and MSN 
materials) and represents occurrences of MSN materials that are trapped in the endosome. 
Avi-B-SS-Amine-MSN and B-SS-Amine-MSN were readily endocytosed by numerous 
cells as is evident in Figures 5 and 7, however BSA-B-Avi-B-SS-Amine-MSN was 
difficult to detect by confocal fluorescence microscopy. Such a difference in the observed 
amount of MSN materials was consistent with the previous data of cellular uptake 
measured by flow cytometry in Figure 5. BSA-B-Avi-B-SS-Amine-MSN showed the 
lowest cellular uptake value; give rise to the lowest fluorescence intensity by the confocal 
microscopy. 
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Material Zeta potential (mV)Ď
a. B-SS-Amine-MSN    -7.2 
b. Avi- B-SS-Amine-MSN  +11.9 
c. BSA-B- Avi- B-SS-Amine-MSN  -27.3 
d. B-SS-Amine-MSN+DTT    -6.8 
e. Avi- B-SS-Amine-MSN+DTT    -3.1 
f. BSA-B- Avi- B-SS-Amine-MSN+DTT   -13.3 
g. Avi- B-SS-Amine-MSN+Trypsin     -4.9 
h. BSA-B- Avidin- B-SS-Amine-MSN+Trypsin   -17.9 
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Figure 5. Cellular uptake of MSN (1 µg ml-1) materials with/ 
without DTT or the treatment of trypsin. 	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Figure 6. Cellular uptake of MSN materials with/  
without the treatment of trypsin. 
Material Zeta potential (mV)Ď
a.MSNĎ -13.1 
b.MSN+avidinĎ   -3.5 
c.MSN+avidin      +trypsinĎ   -9.9 
d.MSN+BSAĎ -18.0 
e.MSN+BSA         +trypsinĎ -17.4 
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Conclusions 
     B-SS-Amine-MSN has a strong affinity for avidin. Avidin immobilized on MSN 
surface improved the accumulation of MSN materials in tumor cells. Also, avidin can be 
regarded as a universal linker between MSN and biotinylated biomolecules. The avidin-
biotin system made it possible to selectively program the endocytosis behavior of MSN 
materials by depositing biomolecules of interest on the MSN surface. When these MSN 
materials encounter a thiol reducing reagent or a protease, they showed distinguishing 
endocytosis behavior that corresponded to the measured surface charge. As a result, the 
endocytosis uptake of MSN materials with biotin moiety can be easily adjusted. The 
range for cellular uptake of B-SS-Amine-MSN was much greater than the control 
unfunctionalized MSN. Another advantage of this system is that the cellular uptake can 
be adjusted in a short time period. The endocytosis efficiency can be administrated 
coarsely or finely. This system demonstrates that controlled uptake of MSN materials for 
tumor cells have potential to be practical. 
 
 
Figure 7. Fluorescence confocal micrographs of HeLa cells after a 17-h 
incubation with B-SS-Amine-MSN (a), Avi-B-SS-Amine-
MSN (b) and BSA-B- Avi-B-SS-Amine-MSN (c). 	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CHAPTER 5. GENERAL CONCLUSIONS 
 
Mesoporous silica nanoparticle (MSN) materials have demonstrated their significant 
potential in biological applications due to their excellent drug delivery and endocytotic 
behavior. It was initially reported that the endocytosis of MSN materials is dependent on 
the surface functionality. However, there has been minimal study determining the 
endocytosis of MSN with bound biomolecules. Thus, we aimed to gain a greater 
understanding of the role of surface bound biomolecule on the behavior of endocytosis of 
MSN materials. 
First, MSN materials were covalently functionalized with conformation specific 
bioactive molecules (either linear or cyclic RGD ligands). Small peptide RGD ligands on 
the MSN surface were tested to determine if they behave towards mammalian cells in a 
similar manner as the free ligands. RGD immobilized on the MSN surface did not 
influence the hexagonal arrangement of the porous matrix and improved the endocytosis 
efficiency of the MSN materials through the receptor-associated pathway. Through 
competition experiments with free RGD ligands, a conformation specific receptor: 
integrin association was discussed. The interaction between RGD immobilized on the 
MSN surface and integrins plays a significant role in endosome trafficking, specifically 
controlling the kinetics of endosomal escape. If surface bound RGD ligands are 
associated more strongly with cell receptor integrins, the uptake of MSN materials by 
cells is more effective but microscopy results indicate that their escape from endosomes 
is slower. Thus, covalent functionalization of biomolecules on MSN assists in the design 
of a system for controlling the interface with cancer cells. 
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Furthermore, the exocytosis of MSN materials opens the door for additional 
bioapplication. Magnetic mesoporous silica nanoparticles with the desired functionality 
were designed for the protein sequestration study.  The silica materials with the non-, 
amino propyl, carboxylic acid, and hydrophobic functional groups were used in the 
protein sequestration experiments.  The normal healthy human umbilical vein endothelial 
cells (HUVECs) and human cervical cancer cells (HeLa) were treated with four types of 
materials to investigate the relationship between the silica surface bound functional group 
and the harvested proteins from both cell types. We determined that the cell types can be 
distinguished with the treatment of materials with the different functional groups. When 
varying the surface functional groups, mesoporous silica nanoparticle materials can 
transport a diverse population of intracellular proteins during the exocytosis process. 
Although the density of harvested protein is quite dilute, the valuable information that 
MSN materials could approach Golgi and ribosome is revealed. Thus, mesoporous silica 
nanoparticles with the designed surface could report the specific cellular process or the 
travel pathway of exocytosed nanoparticles. 
Finally, the protein, bovine serum albumin (BSA), is noncovalently linked to the 
external surface of biotin functionalized mesoporous silica nanoparticle (MSN) materials 
through the avidin-biotin bridge with a cleavable disulfide ligand. This system was 
designed to identify how the biomolecule functionalization on MSN surface influences 
the endocytosis efficiency of mesoporous silica nanoparticles toward cancer cell HeLa. In 
chapter 2, small peptide RGD ligands were covalently functionalized on MSN surface. In 
chapter 3, the proteins were immobilized on MSN surface noncovalently. Proteins on 
MSN surface can be used as caps in drug delivery system or targeting ligands for 
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endocytosis of MSNs into cells. A method for dual layer protein deposition on MSN 
surface was developed to control the endocytosis behavior toward cells. Surface bound 
avidin and BSA gave rise to the opposite effect for endocytosis of MSNs. These materials 
treated with DTT and the enzyme, trypsin, changed their endocytosis behavior as well. 
The endocytosis efficiency of MSNs can be administrated coarsely or finely by surface 
bound protein types, thiol reducing reagents, or proteases. 
In summary, surface biomolecule ligands on MSN will improve the endocytosis 
efficiency of MSN materials. MSN materials can approach the important organelles in 
the cytoplasm. The combination of the advantages of endocytosis of MSN with desired 
functionality and information revealed by the study of the exocytosis of MSN would 
boost the design of well-controlled MSN-based drug delivery system. 
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